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ABSTRACT 
Two studies were undertaken to investigate the relationship between upper respiratory tract 
infection (URTI) and exercise performance. The first study documented the incidence of URTI in 
an athletic population and the second study determined the effect of URTI on exercise 
performance during the recovery period. Endurance runners (n=29) were used for these studies 
and the athletes were monitored for 45 months. During this time the subjects ran an average of 
40 kilometers/week. 
In the first study, 22 reports of symptoms (n=22) of URTI occurred during the 45 month period. Of 
these, 10 subjects (n=10) were ill for less than 3 days. All 10 subjects reported their symptoms 
directly following an endurance event. The other 12 subjects (n=12) were ill for 5 days and longer 
and fulfilled the inclusion criteria for illness due to infection. The incidence of symptoms of 
URTl/1000 hours of training for the group of 29 runners was 1,26. The incidence of symptoms for 
the 10 athletes not fulfilling the inclusion criteria for illness was 0.58 and the incidence for the 12 
athletes fulfilling the inclusion criteria was 0.69. The odds ratio for the athletes (n=22) for 
developing symptoms of URTI during a year is 1.03 compared to the odds ratio of 2.5 for the 
general population during the similar period. These results seem to indicate that 45% of athletes 
(n=10) who reported URTI symptoms directly following strenuous exercise do not have clinical 
infection. Furthermore, the study indicates that regular, moderate, endurance exercise may afford 
protection against URTI, when compared to the general population. 
In the second study, 5 athletes (n=5) of the original 12 subjects with URTI complied with all the 
test protocols. On recruitment, baseline tests were done for muscle strength, muscle endurance, 
aerobic endurance and maximal effort to exhaustion. Following the development of the URTI, the 
above parameters were tested over six days on days 0, 2, 4 and 6. After regaining their pre-
illness fitness levels over a three month period, the subjects were detrained for comparative 
periods and the above tests repeated on similar days for comparative purposes. 
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Parameters for muscle strength and muscle endurance [Work (Joule), Power (Watt), Torque to 
mass (Nm/kg), and Total power (Watt)] appeared to be unaffected following periods of illness and 
following comparative periods of detraining. 
Following detraining, respiratory oxygen absorption 0,/02) (Fully fit 4.28 ±1.98 ml/kg/min ; 
Detrained 6.14 ±1.03 ml/kg/min [p=0.03D, respiratory carbon dioxide expiry 0,/C02) (Fully fit 
277.8 ±102.4 ml/kg/min; Detrained 402.8 ±100.1 ml/kg/min [p=0.04]) and metabolic units (METS) 
(Fully fit 1.22 ±0.55 METS; Detrained 1. 74 ±0.27 METS [p=0.04)) were increased significantly at 
rest on day 2 and respiratory frequency (RF) (Fully fit 70.22 ±10.44 breaths/min; Detrained 51.04 
±7.83 breaths/min [p=0.03)) were significantly decreased and volume of air inspired and expired 
0,/'e) (Fully fit 94.86 ±32.16 I/min; Detrained 130.4 ±23.9 I/min [p=0.05]) were increased 
significantly on day O at maximal performance. Following illness, V02 and METS were 
significantly increased on day O 0,/02 - Illness 43.06 ±5.52 ml/kg/min; Detrained 40.74 ±4.23 
ml/kg/min [p=0.03)) (METS - Illness 12.30 ±1.57 METS; Detrained 11.64 ±1.22 METS [p=0.02)) 
and day 2 0,102- Illness 41.46 ±4.61 ml/kg/min; Detrained 39.72 ±3.15 ml/kg/min [p=0.04)) 
(METS - Illness 11 .82 ±1.24 METS; Detrained 11.36 ±0.88 METS [p=0.04)) after running for 40 
minutes at 70% of maximal effort. Furthermore, at maximal effort following illness, V02 and 
METS were significantly decreased on day O (V02 - Illness 53.4 ±6.06 ml/kg/min; Detrained 58.7 
±7.45 ml/kg/min [p=0.01)) (METS- Illness 15.26 ±2.32 METS; Oetrained 16.78 ±2.12 METS 
[p=0.01)) and VC02 and V'e were significantly decreased on day O (VC02- Illness 3920 ±663 
ml/kg/min; Detrained 4753 ±835 ml/kg/min [p=0.002]) 0,/'e - Illness 103.7 ±18.7 I/min; 
Detrained130.4 ±23.9 I/min [p=0.02)), day 2 (VC02 - Illness 4253 ±913 ml/kg/min; Detrained 
4553 ±694 ml/kg/min [p=0.02)) 0,/'e - Illness 114.4 ±25.1 I/min; Detrained 125.6 ±21 .8 I/min 
[p=0.02)) and day 6 (VC02 - Illness 4566 ±734 ml/kg/min; Detrained 4689 ±1077 mVkg/min 
[p=0.01]) (V'e - Illness 132.4 ±19.31/min; Detrained 135.9 ±22.41/min [p=0.003)). 
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The study indicates that URTI has a significant influence on parameters of respiratory function 
(increased V02 and METS) during submaximal endurance on the first two days only following the 
illness. However,- URTI has a significant influence on parameters of respiratory function 
(decreased V02, METS, VC02 and V'e) at maximal exercise during the first six days following the 
illness. Furthermore, the significant effects on respiratory function are not due to detraining alone. 
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INTRODUCTION AND SCOPE OF THE THESIS 
One of the concerns all sports people have is the possibility of developing an illness. Achieving success 
in sport requires dedication and consistent training. This is especially true of endurance sports where 
the preparation for an event can involve many months of carefully calculated and scheduled training. 
The aim of training is to allow the athlete to reach his or her peak of ability on the day of the event and 
an untimely, forced break from training program may negatively affect optimum performance. 
Upper respiratory tract illness (URTI) occurs more commonly than all other illnesses combined in the 
general population, and therefore has a frequent and often negative influence on an athlete'& training or 
performance (Nieman 1994). However, there is conflicting anecdotal evidence concerning the 
incidence and relative risk of acquiring upper respiratory tract illness among sportspersons. Some 
athletes and coaches believe that consistent training affords protection against acquiring upper 
respiratory tract Illness, while others claim that exercise training increases the risk of acquiring such 
illness. 
When contracting an upper respiratory tract illness the athlete needs to stop training for the duration of 
the illness. In addition to this period of detraining the illness per se might have a debilitating effect on 
fitness levels. It Is thus quite understandable that the individual will limit this period of inactivity, contrary 
to sound medical advice as well as any physiological impediment caused by the disease. Many athletes 
therefore return to training before regaining full health. The effects of upper respiratory tract Illness on 
exercise performance in the recovery period have not as yet been well investigated. Most studies done 
on this subject investigated the effects illness have on athletes whilst they are symptomatic. The effects 
of the upper respiratory tract illness on exercise performance immediately following the illness are not 
known, nor is It clear how much of this effect is due to detraining. 
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This study documents the incidence of upper respiratory tract illness In a cohort of active runners over a 
period of 45 months. In those who developed upper respiratory tract Illness further measurements were 
made in order to determine the relative contribution of the illness itself and a possible detraining effect 
to any post-illness performance deficit. Physiological parameters, exercise performance and muscle 
strength were measured in those athletes who developed upper respiratory tract illness once they were 
a$ymptomatic, and then again after a period of detraining of equal duration to their illness. 
The results of these investigations are then examined in relation to the published literature on the 
incidence of upper respiratory tract illness and the effect these have on exercise performance. These 
findings serve to clarify an understanding of exercise as a risk factor for upper respiratory tract illness 
and also the effect of such an illness on exercise performance during the recovery period. 
This information has important applications for the athlete who develops upper respiratory tract illness 
during training or prior to competition. The athlete requires guidance on the effects that the illness might 
have on his/her training schedule and performance. The clinician must be able to give advice, that is 
based on sound clinical evidence, on when an athlete could resume training and return to competition. 
Furthermore the medical practitioner or coach should be able to advise the athlete on how the period of 
detraining, in addition to being ill, could affect the exercise performance immediately following upper 




2.1 UPPER RESPIRATORY TRACT ILLNESS 
2.1.1 INTRODUCTION 
The common cold is the most frequently occurring upper respiratory tract illness (URTI) in humans, 
accounting for 50% of absenteeism from work or school (Aquilina et al. 1980). Two thirds of respiratory 
tract illnesses are caused by viruses and most involve the upper respiratory tract alone. Spread of the 
illness readily occurs in the course of sporting activity, where transmission can take place in change 
rooms, hotels, living areas, eating and travelling together (Sharp 1989), and as such, this illness is a 
persistent threat to the training and performance of the athlete. Nevertheless, it is believed by many 
athletes and the general public that good physical conditioning helps prevent illness, and being 
deconditioned increases susceptibility to common ailments (Nash 1986; Simon 1987). 
Upper respiratory tract illness (URTI) may impair physical performance due to a variety of reasons. It 
has been shown that acute febrile illness may adversely affect neuromuscular transmission (Friman et 
al. 1977a). Myocarditis may develop as a complication of acute infectious illness (Friman 1976) and in 
response to URTI, skeletal muscle can develop enzymatic and ultrastructural alterations which 
correspond to those found in other forms of muscular diseases (Astrom et al. 1976; Friman et al. 1991). 
A factor that can also influence physical performance during URTI is the effect of medication taken 
during febrile illnesses. It is documented that decreased physical performance may be prevented during 
URTI by symptomatic treatment. It is suggested that this apparent beneficial effect may be influenced 
by the degree of averse subjective impressions of a patient with respect to the severity of the illness. A 
feeling of well-being seem to prevail in athletes whose performance did not deteriorate appreciably. 
This result might have been due to the effect of aspirin and/or propoxyfene which was administered to 
the athletes during the study. (Beisel et al. 1974). 
2.1.2 DEFINITION, TERMINOLOGY AND CLASSIFICATION OF UPPER RESPIRATORY TRACT 
ILLNESS. 
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Upper respiratory tract illness consists of a number of acute infections that occur in the upper portion of 
the respiratory tract. The upper respiratory tract is defined as the nasal passages, naso pharynx, 
pharynx, larynx, trachea, and main bronchi. URTI is caused by viral, bacterial or fungal organisms that 
cause inflammation of the upper respiratory tract organs. The term "cold" is usually defined as •an 
acute illness that involves nasopharyngitis characterised by catarrh, little or no fever and insignificant 
systemic symptoms" (Heath et al. 1992). Viral infections can also result in widespread systemic 
inflammation including cardiac muscle. This could result in injury to the miocardium when stressed 
during exercise. If unchecked, some of these infections can easily progress to the bronchioli and lung 
tissue proper. The symptoms and signs of the illness are important clinical indicators to differentiate 
among the many causative agents (Heath et al. 1992). 
2.1.3 MICROBIOLOGY OF UPPER RESPIRATORY TRACT ILLNESS. 
Many organisms cause upper respiratory tract illness (Table 2.1). These infective agents will be 
discussed briefly. 
2.1.3.1 Rhino Viruses 
These viruses have more than 100 serotypes and are the major cause of URTI in adults. These 
infections are characterised by the common symptoms of nasal congestion, rhinorrhoea, pharyngeal 
irritation, sore throat, malaise and sometimes headache. Symptoms begin after an incubation time of 24 
to 48 hours, are self limited and usually subside in less than a week. Viral shedding by nasal discharge 
begins before the onset of symptoms and may continue for 2 to 3 weeks thereafter. 
Spread of the rhino virus is enhanced by crowded living conditions and extended periods of exposure. 
The peak incidence of rhino viral infections occur during the autumn and spring and continues during 
the winter months (Casey et al. 1990). 
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2.1.3.2 Corona Viruses 
(Casey et al. 1990) 
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The second most frequent cause of URTI amongst adults are Corona Viruses. Only two strains have 
been isolated in the laboratory. Although the incubation period is slightly longer and the period of illness 
is usually a bit shorter, the incidence and symptoms are similar to those experienced with Rhino Viruses 
(Casey et al. 1990). 
2.1.3.3 Influenza Viruses 
The next most frequent cause of URTI in adults are Influenza Viruses of which three types (A B and C) 
are recognised. Although these viruses have the same incubation period, symptoms and incidence as 
Rhino- and Corona viruses, they usually cause epidemics that result in severe complications like viral 
pneumonia or secondary bacterial infections resulting in pneumonia (Casey et al. 1990). 
2.1.3.4 Para-influenza and Respiratory Syncytial Viruses 
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In infants and young children these viruses are important causes of severe respiratory illnesses. Since 
most adults have been infected with these viral serotypes during childhood, re-infection usually causes 
mild illness. The incubation, symptoms and incidence mimics those of Rhino- and Corona Viruses 
(Casey et al. 1990). 
2.1.3.5 Enterlc Viruses 
Several of the enterlc viruses, including the Echo and Coxsackie Viruses, may cause upper respiratory 
tract Illness in infants, children and adolescents during the summer and autumn months. These do 
probably not cause acute adult respiratory Illness (Casey et al. 1990). 
2.1.3.6 Herpes Simplex Type I and II 
Herpes simplex type I and II cause upper respiratory tract illness which Is characterised by symptoms of 
mild cold followed by oropharyngeal ulcers, tonsillitis, pharyngeal inflammation and exudate, tender 
cervical and submandlbular adenopathy and fever. The illness is self limited lasting 2 to 3 days and 
have no distinct seasonal peak (Casey et al. 1990). 
2.1.3.7 Adenoviruses 
Adenoviruses are not common agents for illness in the adult population and infections occur only 
sporadically during winter and early spring and are characterised by fever, pharyngitis, laryngitis, 
rhinorrhoea and hoarseness. The incubation period is 6 to 9 days and the disease has a clinical course 
of 1 to 2 weeks. Viral pneumonia is a common complication (Casey et al. 1990). 
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2.1.3.8 Mycoplasma pneumoniae 
Respiratory infections caused by Mycoplasma organisms may be seen throughout the year. Incubation 
takes from 1 to 3 weeks and the illness is almost Invariably self limited to 3 weeks or less. Symptoms of 
infection usually begin in the upper airway with pharyngitis and tracheitis being the most prominent. 
Malaise, mild fever and myalgia may be present and cough is the most common symptom. The disease 
can be complicated by pneumonia when the infection spreads to the bronchioles and lungs (Casey et 
al. 1990). 
2.1.3.9 Chlamydiae 
The Chlamydiae genus contains two species, C trachomatis and C psittaci. C trachomatis is known to 
cause pneumonia in infants and immunocompromised adults. C psittaci causes pneumonia In healthy 
adults but is almost universally contracted through exposure to infected birds. 
Recently a new Chlamydia has been isolated and named strain TWAR and this may be an Important 
cause of respiratory disease in healthy young persons. The new strain emerged from epidemics of mild 
pneumonia caused by C psittaci where the illness could not be linked to birds (Casey et al. 1990) 
2.1.3.10 Bacterial Infections 
Among these infections Streptococcus pyogenes remains an important cause of acute pharyngitis of 
which ~-haemolytic Group A is the most important one. Streptococcal pharyngitis occurs most 
commonly during the winter months and has an incubation period of 2 to 4 days. This is followed by 
rapid onset of sore throat, fever, headache, myalgia and malaise. 
Clinically the uvula, pharynx and tonsils are diffusely erythematous and oedematous and there is 
associated cervical adenopathy which may progress to suppurative tonsillitis. Complications known to 
be associated especially with Streptococcus Group A infections are Acute Rheumatic Fever and 
Glomerulonephritis. 
Of the several bacterial pneumoniae only Streptococcus pneumonia will rarely produce a primary 
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illness in young adults. When bacterial pneumonia complicates influenza, Streptococcus pneumonia is 
the most frequent secondary invader followed by StaphyJococcus aureus and Haemophilus influenza 
(Casey et al. 1990). 
2.1.3.11 Legionnaires disease 
Legionella pneumophila is a unique species in microbiology and not related to any other environmental 
or pathological organism. The organism is part of flora, naturally occurring in water and damp 
environment, and capable of surviving in extreme ranges of environmental conditions. Human infections 
have been associated with contaminated cooling towers, air conditioning systems, damp excavation 
sites and respiratory equipment. The incubation period is 2 to 14 days and the illness presents as acute 
bacterial pneumonia. Symptoms are malaise, fever, muscle aches, dyspnoea and headaches. Other 
symptoms may include confusion, ataxia, abdominal pain and diarrhoea. On examination pulmonary 
rhonchii are usually heard and a chest X-ray shows patchy consolidation (Strebel et al. 1988; Marik 
1989). 
2.1.3.12 Summary of microbiology of URTI 
It is clear that many organisms can be the cause of URTI. This presents a challenge to the clinician in 
diagnosis and treatment. All of the organisms discussed have similar symptoms and signs of URTI. 
Some bacterial infections have unique additional clinical signs that assist in diagnosis, but the other 
organisms can only be identified serologically or by culture. Irrespective of the causative organism the 
illness results in a period of debilitation. At presen~ it is not known what effect the illness and it's duration 
has on exercise performance. 
2.1.4 PATHOGENESIS OF VIRAL UPPER RESPIRATORY TRACT ILLNESS. 
Influenza can spread rapidly and should never be underestimated. It may have serious consequences 
for the athlete who continues training or competing. Attempting to "sweat it out" can be an extremely 
dangerous practise if the individual has systemic symptoms such as fever and tachicardia and may lead 
to permanent damage to the myocardium (Sharp 1989). The many causative agents, as discussed, 
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have different pathological effects on the tissues they invade. 
Viruses cause an acute interstitial infiltration of lymphocytes, histiocytes and plasma cells resulting in 
widespread inflammatory response of the upper respiratory tract tissues. Bacteria tend to localise the 
inflammation to the infected area or tissue but can also cause widespread granuloma formation in 
cases of tuberculosis and other mycobacterium (Knight 1977; Breven 1962). 
Viral upper respiratory tract illness is primarily an infection of the respiratory epithelium that is 
transmitted from one person to another by either inhalation of infective droplet nuclei or by ocular 
inoculation most commonly when the eye is rubbed by a hand carrying the virus. After nasal infection 
the virus multiplies rapidly and spreads to involve the entire nasopharyngeal and tracheobronchial tree. 
At first the mucosa becomes swollen and hyperaemic and loses its norfl'.lal ciliary activity and is then 
followed by necrosis of the respiratory epithelium. Although the infection is largely confined to the 
respiratory tract, viral products can enter the circulation and cause viraemia affecting the heart, kidney 
and other extra pulmonary tissues. Recovery from uncomplicated disease is often complete after 5 to 7 
days (Knight 1977). 
Contrary to popular belief, exposure to a cold environment does not increase the risk of acquiring or 
aggravating an URTI (Simon 1987; Heath et al. 1992). Smoking and psychological stress have been 
shown to be risk factors for developing URTI (Nash 1986; Schouten et al. 1988; Heath et al. 1992). 
2.1.5 EPIDEMIOLOGY OF URTI IN THE GENERAL POPULATION. 
A number of different viruses and bacteria can cause upper respiratory tract illness, all of which have 
the ability to change their antigenic characteristics every few years. As a result they continue to 
challenge personal immunity, despite the availability of vaccines. In general, the number of infections 
acquired per year decrease with age. Infants and children have the highest incidence with 4 to 8 
infections per year. This rate may even double when children are in day care or in nursery school. In 
school-aged children the incidence is 2 to 6 upper respiratory tract infections per year. Adults acquire 2 
to 5 upper respiratory tract infections per year, with women and adutts who live in households with 
children tending to suffer even more upper respiratory tract infections per year (Heath et al. 1992). 
Table 2.2 Summary of the frequency of causative microblals in upper respiratory 
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Although the incidence of URTI is highest during the winter months, evidence suggests that it Is not low 
temperatures per se that are responsible (Simon 1987; Schouten et al. 1988; Heath et al. 1992). The 
environmental conditions during winter lead to overcrowding, which increases the exposure of persons 
to etiologic agents (Brenner et al. 1994). 
Transmission of both rhino- and corona viruses appear to result mainly from inhaling infected droplets. 
Another method is self-inoculation of nasal mucosa and conjunctlvae by fingers that have been in 
contact with the virus (Brenner et al. 1994; Heath et al. 1992). In addition, strenuous exercise may 
decrease local nasal mucosa antibodies and thereby reduce resistance to respiratory infections 
(Aquilina et al. 1980). 
/ 
2.1.6 CLINICAL PRESENTATIONS AND COMPLICATIONS OF UPPER RESPIRATORY TRACT 
ILLNESS. 
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Acute upper respiratory tract illness is an acute febrile illness lasting about one week and characterised 
by fever, cough, hoarseness and sore throat. Pharyngitis is the most prominent localised manifestation 
of the disease and reaches maximum severity after about three days. The illness is accompanied by 
general malaise and headache. Nasal congestion and obstruction occurs commonly and cough and 
hoarseness of the voice is frequent. Diffuse myalgia occurs in almost half the cases and this is 
particularly marked in the legs and over the lumbosacral area. A rise in temperature occurs which is 
accompanied by tachycardia and can last for up to seven days (Knight 1977). 
The main complication of upper respiratory tract Illness is pneumonia. This occurs as either primary 
pneumonia due to the virus infection per se, or secondary pneumonia due to bacteria which cause 
infections on the lesions produced by the virus. Other complications are bacterial infections of the 
paranasal sinuses or middle ear. Rarely viral upper respiratory tract illness can be fatal in individuals 
with pre-existing pulmonary or cardiac disease, regardless of age (Knight 1977). 
Sudden death of athletes during participation in sport has been linked to viral myocarditis caused by 
febrile illness such as upper respiratory tract illness. In these cases, cardiac abnormalities at autopsy 
are focal microscopic myocyte necrosis and lymphocyte infiltrate. It Is speculated that acute exercise in 
the face of myocarditis triggers an arrhythmia which can be fatal (Eichner 1993). 
2.1.7 MANAGEMENT OF UPPER RESPIRATORY TRACT ILLNESS. 
The severity of upper respiratory tract Illnesses in practise can be a mild, uncomplicated, symptomatic, 
common cold or be more debilitating influenza. Influenza can be complicated by primary or secondary 
infections of related organs leading to otitis media, sinusitis, bronchitis or pneumonia (Knight 1977). In 
general, the initial treatment of URTI is focussed on symptomatic relief. If URTl's are prolonged, severe 
or complicated they are best treated with bed rest combined with the appropriate antibiotic. 
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Physiotherapeutic measures can be employed to assist in clearing chest and sinus infections (Beisel et 
al. 1974). 
The sports physician is often faced with the decision whether athletes should be allowed to exercise 
when they have an upper respiratory tract lllness .. The accepted recommendation Is that if the athlete 
has symptoms of a common cold with no constitutional involvement, regular training may be safely 
resumed a few days after resolution of symptoms (Simon 1987). However, if there are symptoms or 
signs of systemic involvement such as fever, fatigue, muscle aches or lymphadenopathy, then 2 to 4 
weeks should be allowed before resumption of more intense training. These precautions are advised 
because of the potential relationship between intense exercise and the risk of developing viral 
cardiomyopathy and other severe forms of viral infection (Heath et al. 1992). 
Eichner (1993) describes a simple protocol (the 'neck check) for determining whether exercise is 
appropriate or not under conditions of URTI. If all symptoms were ' above the neck' (runny or blocked 
nose, sore throat), the athlete could commence an exercise routine at below normal intensity for about 
10 minutes. If such activity makes them feel worse, they should stop exercising but if they feel better 
they may continue the training session. If symptoms were ' below the neck' however (muscle aches, 
cough, vomiting, diarrhoea or fever), training should be discontinued. 
2.1.8. PREVENTION OF UPPER RESPIRATORY TRACT ILLNESS. 
Although clinical experience and epidemiological data seem to indicate that there is increased risk of 
upper respiratory tract illness in some athletes (Eichner 1993), the balance of evidence favours the view 
that psychosocial variables play an important role in effecting immunological competence (Heath et al. 
1992). This together with the physiological stress from heavy endurance exercise may lead to 
suppression of the immune system (Heath et al. 1992; Eichner 1993). 
Precautions that can help decrease the risk of illness include the spacing of high intensity acute 
exercise bouts and race events as far apart as possible, eating a well balanced diet, keeping other life 
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stresses to a minimum, avoiding overtraining and chronic fatigue and obtaining adequate sleep. 
Table 2.3 Precautions to decrease the risk of acquiring URTI in athletes (Heath et al. 
1992). 
Space strenuous exercise bouts far apart 
Eat weU balanced diet 
Stress management 
Avoid overtraining 
Avoid chronic fatigue 
Adequate sleep pattern 
Avoid contact with people that have URTI 
Isolate team members that have URTI 
Wash hands regularly 
Avoid rubbing of eyes and nose 
Inoculate with flu vaccine 
To minimise exposure to infection athletes should avoid contact with individuals who have symptoms or 
signs of an infectious illness. A team member who develops symptoms should be isolated from the 
other athletes as soon as is practicable. The hands should be washed regularly and rubbing of the eyes 
and nose should be avoided since viruses are often transmitted by hand contact. Inoculation of viruses 
endemic to the area where the athlete will compete may also be helpful (Brenner et al. 1994). 
2.1.9 SUMMARY AND CONCLUSIONS. 
It is well known that upper respiratory tract illnesses are widespread and common in the normal 
population. There is evidence that athletes following vigorous training schedules may be more 
susceptible to URTI. This observation is probably due to an increase in psychological and physiological 
stress that may result in a suppression of the immune system. The many causative agents are mainly 
viral and this can occasionally be complicated by secondary bacterial infections. The dangerous 
. complications that can manifest when athletes exercise whilst suffering from upper respiratory tract 
illness are well documented. However, the effect that upper respiratory tract illness has on exercise 
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performance during the recovery period Is not known. 
There are general guidelines for the athlete to avoid acquiring upper respiratory tract illness. Clinical 
symptoms and signs can be used to assess the severity of the URTI and these parameters can be used 
to advise athletes on whether or not to continue or discontinue exercise training. These parameters are 
however based on common sense rather than sound scientific observations. 
It is clear that there is a definite need for more information on the effect that upper respiratory tract 
illness has on ex9rcise performance. The sports physician should then be able to advise the athlete on 
possible decreases in exercise performance during the recovery from URTI. 
2.2 THE IMMUNE SYSTEM 
The immune system comprises naturally occurring as well as acquired components that function in a 
co-ordinated manner. The main functions are to protect against, recognise, attack and destroy foreign 
infectious agents. The naturally occurring factors serve as a first line of defence when the body 
encounters an infectious agent. Failing this, the acquired factors are activated to combat the ensuing 
infection. This system aids the body to recover from the infection and also develops a memory for the 
infectious agent (Brenner et al. 1994; Nieman et al. 1991; Nash 1986). 
This review will outline the components and functions of the immune system and indicate the process of 
the immune and inflammatory response. This information will then be applied to illustrate how an acute 
exercise bout affects the immune parameters and functions. 
2.2.1. THE FUNCTION OF THE IMMUNE SYSTEM 
The immune response has both cellular and humoral (antibody mediated) factors. The cellular 
components are leukocytes that comprise granulocytes, lymphocytes and monocytes. Granulocytes 
account for 60 to 70% of the circulating leukocytes and consist of neutrophils, eosinophils and 
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basophils. Lymphocytes account for 20 to 25% of the white cells and consist of T -cells, B-cells and 
natural killer cells. In this group the T-cells are classified as either T-helper cells or T -suppressor cells. 
Macrophages are monocytes that enlarge in response to ingestion of foreign material with resultant 
Increase in synthesis of lysosomal enzymes. These macrophages have the function of phagocytosls of 
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Cellular components of the immune response (Nieman et al. 1991) 
T-helper cells recognise antigen presenting or virally infected cells and release cytokines. These are 
proteins involved in the communication between and activation of different immune cells and include 
interleukins, interferons, tumour necrosis factors and colony stimulating factors, each with diverse 
functions. (Nieman et al. 1991; Brenner et al. 1994). One of the main functions of these proteins is to 
attract and activate the host macrophages, which together with monocytes, neutrophils and natural 
killer cells are responsible for the phagocytic function of the immune system. T cells also play a crucial 
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role in modulating and controlling the differentiation of lmmunoglobulin-bearing B cells to 
immunoglobulin--secreting plasma cells in response to antigen invasion, with T helper cells aiding and T 
suppressor cells inhibiting the process. 
lmmunoglobulins are components of the humoral response and are produced by the B-cells and 
plasma cells. Five immunoglobulins are recognised: lgG, lgA, lgM,lgD and lgE. The immunoglobulins 
are known as antibodies and they bind with specific antigens which characterise foreign micro-
or9anisms. The B-lymphocytes carry the lgG, lgA, lgM and lgE on their surface membrane. When the 
immunoglobulins on a B-cell interacts with antigen, the B-cell differentiates into a plasma cell. The 
plasma cells are short lived cells which actively secrete immunoglobulin antibodies. These antibodies 
are specific to the class of antigen they bind with. The antibodies protect the host by binding with the 
surface antigens and agglutlnlsing the micro-organisms. This In turn facilitates phagocytosis, activates 
the complement system, produces opsonlns and neutralises bacterial toxins (Brenner et al. 1994). The 
T-cells have receptors for lgO which are expressed when exposed to antigen and which is associated 
with augmented antibody production (Swenson et al. 1996; Swenson et al. 1998). 
The complement system consists of more than 20 proteins. some of which are proteolytic enzymes. 
These proteins bind with antibodies and are responsible for stimulating phagocytosis, stimulating 
antigen presentation and stimulating the killing of infected cells. lgM is especially effective in activating 
complement to produce immune lysis of foreign cells (Irvine 1974). 
It Is clear that the body has an effective mechanism to defend against foreign organisms. Infection 
initiates an immediate immune response which destroys the organisms with enzymes released from 
host cells and engulfment by host cells. 
2.2.2 IMMUNITY AND THE INFLAMMATORY RESPONSE 
The immediate response of the body to infection is acute inflammation. In the first instance blood flow is 
increased to the infected area and vascular permeability is enhanced to allow the entry of leukocytes 
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and plasma proteins to the infected area (Brenner et al. 1994). This inflammatory reaction also serves 
to mobilize nutrients for the increased needs of the immune system (Friman et al. 1998). 
The immune response is initiated when a macrophage engulfs a foreign organism and then processes 
and incorporates the foreign proteins into its own cell surface. The foreign proteins are antigens and the 
macrophage is known as an antigen presenting cell. This antigen presenting cell comes into contact 
with 8-cells and T-cells (Brenner et al. 1994; Austen 1977). 
The 8-cells produce immunoglobulin antibodies that bind with the antigen to form free Immune 
complexes that are rapidly removed from the circulation by phagocytosis. The antibodies also bind with 
tissue and activate complement which is responsible for triggering phagocytosis. The B-cells 
differentiate into either plasma cells that secrete large amounts of the specific immunoglobulin, or into 
resting 8-memory cells. The 8-cells rapidly transform into plasma cells following a second exposure to 
the antigen. Resistance to the infection is thus in part due to the presence of adequate levels of antigen 
specific antibodies (Nieman et al. 1991; Austen 1977). 
T -cells are also activated by the presenting antigen and they serve to modulate the development of 
immunoglobulin secreting plasma cells from 8-cells, with T-helper cells aiding and T-suppressor cells 
inhibiting the process. The activated T-helper cells produce soluble factors (cytokines) that bind to the 
specific receptors in the activated B-cells to give signals for growth and differentiation. These soluble 
factors are interleukin, interferon, B-cell growth factors and B-cell differentiation factors (Nieman et al 
1991). Different components of the immune response react to different types of infectious agents. 
Bacteria and fungi are removed through phagocytosis by macrophages and neutrophils, eosinophils are 
responsible for the elimination of parasites and T -cells are prominent in the defence against viruses 
(Brenner et al 1994). 
2.2.3 THE EFFECTS OF EXERCISE ON THE IMMUNE RESPONSE 
Numerous studies (listed in Table 2.4) have documented the effects that exercise has on the immune 
19 
system. There is evidence that prolonged submaximal exercise might stimulate the immunity and thus 
have a protective effect, whereas acute and high intensity bouts might suppress the immunity and have 
a negative effect. In studies describing the relationship between an acute bout of exercise and the 
immune system, there has been considerable variations of exercise intensities. For the purpose of this 
dissertation the exercise intensities have been graded as mild, moderate or strenuous. Table 2.4 
summarises the type of physical activity used by various researchers to achieve mild, moderate or 
strenuous effort. 
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Table 2.4 Summary of physical activities used to achieve different exercise intensities by 
researchers examining the effect of exercise on immune system function. 
Aldllors Levels of Exertion 
Mild Modentl auuuous 
l"aortnan 1179 Graded maximal treadmill test 
ElleffMu« 1971 20min. cycle O 130kgm/min 
Eskolattal.1179 Trained runners running marathon O Elite runners running marathon O 
i;ubmaximal pace maximal pace 
Ha-tt•Lt9S1 13km running O 72" V02 max 
Graded maximal treadmill test 
-,--a.taL1NI 
MNKla-.tal.1N7 2 hours cycling O 70 ID 75'11, V02 
max 
Lewicki lit al 1917 Graded maximal cycle test 
ScllonNtlll Graded maximal treadmill test 
NllaaalltaLtNI Graded maximal treadmill test 
TvNeetalt"8 1 hour cycte O 80'11, V02 max 
........ lll.tllO 60 minutes C}«:Hng O 75'11, V02 
Max 
.... etaLtllO 1 hour cycle O ~ V02 Max 
........ 1.1990 45mln. walking @ 6()'ll, V02 Max 5x More than 97km running per week 
per-k 
IIUuN lltal. 1NO OOmln. Running O 63'!1, V02 max 
Ila-• Ital. 1111 Running 1, 7 to 10,5 km at close 
to maximum s......,. 
NIHaa lltal.1991 45min. walking @ 6Q'!I, V02 Running less than 40km O 7()'11, V02 Running 45 ID 75km 
Max 5x per week Max 
Nllaa1.taLtNt 3 hours running G marathon pace 
l.Nehl1N2 Basic army cadet orienteering Basic army cadet training 
-33 increase in rate of perceived 
exertion 
Ek111Nr11n Running less than 20 miles per -k Running more than 60 miles per 
week 
Gabriel et aL tiff <2 hours ~ 85'11, of Individual Exhaustive exercise O 10Q'II, IAT or 
Anaerobic reo;hold OAn above 
IIMkll- .taL 1191 Running o sin~e bout of 40 ID 90 Running for 90 min O 75'11, V02 max 
minutes O 55 to 75'11, of V02 max. on three consecutiYe days. 
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Based on the information presented in Table 2.4 mild exercise can be defined as training at 60% of V02 
max, moderate exercise as running less than 40km In one bout at 75% V02 max and strenuous 
exercise when running more than 45km in one bout or completing a graded maximal exercise test 
(Table 2.5). 
Table 2.5 Stratification of exercise intensity based on infonnation detailed in Table 2.4 
above 
Level of exertion 
Mild Moderate Strenuous 
Exercise type Training at 60% of V02 Running less than 40km in Running more than 40km 
max one bout at 75% V02 max in one bout 
Or 
a graded maximal exercise 
test 
Studies have been conducted to determine the effect of various intensities of exercise on the immune 
parameters. Results of some of these studies during mild, moderate and strenuous exercise are 
summarised In Tables 2.6, 2.7, 2.8, 2.9 and 2.10. Most studies conclude that all intensities of exercise 
cause an increase in the leukocyte count due to specific increases in natural killer cells, neutrophils and 
monocytes. There Is a concomitant decrease though in the T and B lymphocytes with all intensities of 
exercise. 
Studies on the effect of exercise on humoral parameters have produced conflicting results (Nieman et 
al. 1991; Nieman 1997a). It has been suggested that the changes in plasma volume due to exercise is 
responsible for the apparent Increases in soluble factors. Following maximal exercise. plasma volume 
reductions of 12%-16% has been reported (Nieman et al. 1989; Stephenson et al. 1985). These 
plasma volume changes could explain the 8% - 18.5% increases in immunogtobulin and complement 
reported by Nieman et al. (1989) immediately following graded maximal exercise. Conversely, it has 
been argued that exercise has no effect on the humoral factors (Brenner et al. 1994; Lewicki et al. 
1987; Fitzgerald 1988). 
Tables 2.6, 2.7 and 2.6 list the findings of various authors on the effects of mild, moderate and 
strenuous exercise on cellular and humoral immune factors. 
Table 2.6 The effect of mild exercise on cellular and humoral immune factors. 
Mild Exercise 
Author Exercise type and Immune Parameters 
Intensity 
Cellular Humoral 
T~ ~ NKO Nel lllotlo ... 11A .... eon. , ... , ... Aet , ... Cout 
Lee et al 1992 Basic army cadet ,1. 
orienteering 
Smith et al. 1 hour cycle@OO%V02 N t.i 
1990 Max 
Nieman et al. 45mln. walking @ 00% ,1. t t t 
1990 V02 Max 5o< per week 
Mackinnon et Jogging for ,«> min @ ffi% 
al.1994 to 75% of V02 max N 
Abbreviations: T -lymph func =T-lymphocyte function, B-lymph func =B-lymphocyte function, NKC act=Natural KIiier CeU activity, 
Neut func =Neutrophil function, Mono count =Monocyte count, lgG=lmmunoglobulin G, lgA=lmmunoglobulln A, 
lgM=lmmunoglobutin M, Comp--complement, J.=decreaae, t=increase, N • no significant Increase or c:tecrea&e. 
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Table 2.7 The effect of moderate exercise on cellular and humoral immune factors. 
Moderate Exercise 
Author Exercise Type and Immune Parameters 
Intensity 
Cellular Humoral 
T..ivn.ti ~ .. KC Nellt IIOll4I IIG '8A .... co,,. , ... ..... Act P'UIIO Cowat 
Gabriel et Exercise <2 hours at 85% t al 1997 of individual anaerobic 
threshold 
Nieman Long term exercise training t 1917a 
Lee etal. Basic army cadet trainng- ,I, 
1992 32% increase In rate of 
perceived exertion 
Ricken et Ennin running @ 63% V02 ,I, N 
al.1990 Max 
Pederson lnnin cycling @ 70% V02 t ,I, t 
etal.1990 Max 
Tvedeet OOmin cycling @ 80'll, V02 ,I, ,I, 
al.1989 Max 
MacKlnne 120nin cycling @ 70-75% N N N 
net al. V02Max 
1917 
Hanson et 13km running@ 72'll, V02 N N N 
al.1981 Max 
Eskola et Trained runners running N N 
al.1978 marathon @ submaximal 
pace 
Eberhardt 20nin cycling @ 
N N N 1971 1ngrnhnin 
Abbreviations: T -lymph func cT -lymphocyte function, B.Jymph func :sB-tymphocyte function, NKC act=Natural Killer Cell activity, 
Neut func =Neutrophil function, Mono count=Monocyte count, lgG=lmmunoglobulin G, lgA=lmmunoglobulin A, lgM=lmmunoglObunn 
M, Comp=Complement, +=decrease, t=lncrease, N = no significant Increase or decrease. 
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Table 2.8 The effect of strenuous exercise on cellular and humoral immune factors. 
Strenuous Exercise 
Author Exercise type Immune Parameters 
and intensity 
Cellular Humoral 
T-lyn1»11 ll-lyn1tll NKC NH Mono lgQ lgA 11M Co"" 
Fune funo Act Fune Co1111t 
Bllepllanlet Athletes during periods ..J, 
al 1!191 of heavy nining 
l'yM etaL Eli!e swimmers during 
..J, ..J, 
1111 Training 
Nlenaa 1997a Periods of heavy nining ..J, 
N ..... a1nn Heavy exertion ..J, ..J, ..J, ..J, 
GalllrteletaL Exhaus1iw exercise at ..J, 
1117 10()'!(, of individual 
an.erobic threshold 
H-et•L1N1 Running 1,71D 10,5 km at close ..J, ..J, 
1D maximum speed 
N ..... aetaL1990 More than 97km running per t 
week 
NleffaattaL1911 Graded maximal treadmill t,,st ..J, ..J, N ..J, 
8ollclma It ••• Graded maximal trndmill test t..J, 
1911 
i..-tcty et al 1917 Graded maximal cycle test ..J, t 
llltpllenoa etaL Graded maximal treadmill test t N N ,_ 
Eaa et •L 1171 Elite runnen; running marathon ..J, ..J, 
@ maximal pace 
P'Nt1maH 1970 Graded maximal treadmill test 
t t 
Abbreviations: T-lymph func =T-lymphocyte function, B-lymph func :::iB-lymphocyte function, NKC act=Natural Killer Cell activity, 
Neut function =Neutrophil function, Mono count=Monocyte count, lgG=lmmunoglobulin G, lgA=lmmunoglobulin A, 
lgM=lmmuooglobulin M, Comp=Complernent, .L.=decrease, t=increase, N = no significant increase or decrease. 
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Table 2.9 Summary of immune responses during mild, moderate and strenuous exercise. 
Immune Exercise intensity 
Response 
Mild Moderate Strenuous 
Cellular 
Leukocyte count t t t 
Lymphocyte i i i 
function 
Natural killer cell t t t 
activity 
Neutrophil function i i i 
Monocyte count t t 
Humoral 
lmmunoglobulin ti ti tN 
Complement i 
Abbreviations: +=decrease, t=increase, N = no significant Increase or decrease. 
Strenuous exercise comprises long endurance exercise and acute bouts of high intensity exercise. As 
indicated in Table 2.5, most authors accept long endurance exercise as running more than 40km 
(Nieman et al. 1991 ; Nieman et al 1990) and acute exercise as a graded maximal exercise test The 
graded maximal exercise tests are commonly performed on a treadmill where the subjects are 
exercised to exhaustion (Nieman et al. 1989b; Schouten et al. 1988; Stephenson et al. 1985; 
Poortmans 1970). 
Changes in the cellular components during exercise have been associated with increases in serum 
cortisol concentrations and serum epinephrine concentrations that take place in response to an acute 
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exercise bout (Eichner 1993). The cortisol and epinephrine blood concentrations increase when 
exercise intensity rises above 60% of maximal performance. Epinephrine has an effect within the first 
hour of exercise and cortisol has an effect after 2 to 3 hours of exercise. During exercise, leukocytes are 
mobilised from the lungs, liver, spleen and muscle due to the Increase in cardiac output and the rise In 
the cortisol and epinephrine levels. Cortisol and epinephrine inhibit lymphocyte entry into the 
bloodstream and increases lymphocyte migration Into the lymphoid tissue which results in 
lymphopaenia (Eichner 1993). The mobilisation of neutrophils and monocytes result in the leukocytosis 
and the total white cell count does not reflect the associated lymphopaenia. Natural killer cells have a 
high density of beta-adrenergic receptors and the natural killer cell count thus increases during exercise 
in response to the increase in serum epinephrine concentration (Eichner 1993). 
Where the above represents the cellular immune response during exercise, most studies show that 
following exercise activities, cellular functions are suppressed (Table 2.10). 
Table 2.10 Summary of immune responses following prolonged endurance and acute 
strenuous exercise. 
Immune Exercise intensity 
Response 











T-helper cells ,l.. 
"' 
T-suppressor cells t t 
Macrophage function ,l.. t 
Abbreviations: J.•decrease, to:lncrease, NKC=natural killer cell. 
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Natural killer cell count and activity is suppressed within 1 to 2 hours following exercise and returns to 
baseline within 6 to 24 hours (Fitzgerald 1988; Pederson et al. 1990; Eichner 1993; Nieman 1997b). 
Monocytes release prostaglandins during exercise and it is thought that these prostaglandins suppress 
natural killer cell activity after exercise. It has been demonstrated that natural killer cell activity Increases 
after exercise if the prostaglandin production is inhibited by ingestion of indomethacin (Pederson et al. 
1990). 
It has been shown that neutrophil phagocytic activity is inhibited following long term endurance exercise 
and acute strenuous exercise (Lewicki et al. 1987; Gabriel et al. 1997; Bury et al. 1998). Contrasting 
evidence demonstrated increased neutrophil microcidal activity after acute strenuous exercise but 
inhibited activity after long endurance exercise. Conversely macrophagic phagocytic activities were 
Inhibited both following acute strenuous and long endurance exercise (Smith et al. 1990). 
Studies on T-lymphocytes also indicated a decrease after acute strenuous and long endurance 
exercise with a return to baseline levels after 24 hours (Nieman 1997b). Observations on the T· 
lymphocyte fractions though indicated that the T-helper fractions decrease but the T ..suppressor 
fractions show an Increase following exercise (Fitzgerald 1988; Ricken et al. 1990). It has been 
suggested that a reduction in the helper to suppressor cell ratio below 1.0 to 1.5 might Indicate 
immunosuppression and could be used tQ identify athletes with an increased susceptibility to infection 
(Nash 1986; Brenner et al. 1994). 
All of the above have the effect of suppressing the immune response by impairing phagocytosls, 
antibody formation, migration of cells to infection site and the ability to kill microbial particles. The 
transient suppression of cell - mediated immunity following exercise might be sufficient to allow micro-
organisms time to evade early immunological recognition and thus establish infection. These results 
might explain the anecdotal observation by athletes and coaches that acute strenuous and prolonged 
endurance exercise, appear to cause an increased risk of upper respiratory tract illness. 
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2.3 EXERCISE AND THE RISK OF DEVELOPING UPPER RESPIRATORY TRACT ILLNESS. 
Physical exercise has an influence on the immune system and changes due to exercise can be induced 
in both the naturally occurring as well as the acquired immune processes (Brenner et al.1994). 
Immune system function can also be an important determinant of the outcome of exercise 
performance following upper respiratory tract illness. 
There is anecdotal evidence that upper respiratory tract illness occurs less commonly in well trained 
athletes than in the general population (Eichner 1993; Nieman et al. 1998). Many athletes believe that 
exercise improves their resistance to infectious disease (Nieman et al. 1989a; Heath et al. 1992; Nash 
1986). In contrast there are repor1s of an increase in upper respiratory tract symptoms following ultra 
marathon participation and following intensive training (Brenner et al. 1994; Heath et al. 1992). Many 
coaches and athletes believe that strenuous exercise during training or competition may cause the 
athletes to be unusually prone to illness, especially upper respiratory tract illness (Nash 1986). 
2.3.1 THE RISK OF UPPER RESPIRATORY TRACT ILLNESS FOLLOWING AN ACUTE EXERCISE 
BOUT. 
Mechanical effects of exercise that could result in exposure to infectious micro-organisms include 
mouth-breathing and drying of the mucosa, slowing of ciliary action due to thickening of the bronchial 
mucosa by inspiration of cold dry air thus slowing clearance of micro-organisms. During contact spor1s 
damage of the skin could occur through trauma which could lead to invasion by micro-organisms 
(Brenner et al. 1994; Heath et al. 1992; Aquilina et al. 1960; Schouten et al. 1988). In interviewing 
marathon runners after a 56km race in the two weeks immediately following the race it was reported 
that 33.3% of the runners developed symptoms such as runny nose, cough or sore throat, compared 
with 15,3% of non-runners. The faster runners also seemed the most likely to report such complaints 
(Brenner et al. 1994). 
In comparison athletes training and participating in shorter distance events did not however seem to 
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alter the likelihood of respiratory complaints. The incidence of respiratory symptom, in 273 runners was 
similar before and after groups participating in short road races of 5, 1 O and 21 km (Nieman et al. 
1989a). This would further support the finding that running less than 40km rates as moderate exercise 
and does not necessarily contribute to increased upper respiratory illness. 
Pederson et al. (1994) suggests an •open window" for increased risk of URTI, in the first few hours 
following strenuous exertion. During this period there is a transient immunosuppression due to 
decreases in the lymphocyte and natural killer cell counts (Table 2.10). It has been reported that these 
cells remain suppressed for 6 to 24 hours following strenuous exercise (Fitzgerald 1988; Pederson et 
al. 1990; Eichner 1993). During this period the athlete is most vulnerable to URT infection. 
Nieman 1994 proposes a • J" shaped curve when comparing moderate, regular exercise and strenuous 
exercise to sedentary controls with the risk of acquiring URTI (Figure 2.2). The curve Indicates that 













Intensity and Volume of Exercise 
Competition 
overtraining 
"J" shaped model of relationship between ranging amounts of exercise and risk of 
URTI (Nieman 1994). 
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In a study by Nieman et al. (1989a) runners were analysed according to average miles per week in 
training (those training more than 15 miles per week and those training less than 15 miles per week). 
The study compared the incidence of upper respiratory infectious episodes in 273 runners during a 2 
month training period prior to a 5km, 10km and half marathon race. Furthermore the incidence on 
infectious illness following the races were studied. 25% of runners training more than 15 miles per week 
reported one infectious episode compared to 34.3% of runners training less than 15 miles per week. 
Only 6.8% of runners preparing for the half marathon reported sick with flu compared to 17 .9% of the 
5km and 10km runners. During the week following the race runners did not report an increase In 
infectious episodes as compared to the week prior to the race. These findings suggest that runners 
exercising at high intensity are less at risk for acquiring infectious illness compared to recreational 
runners. Furthermore, that the act of participating in a race does not appear to be associated with an 
Increase in risk of acquiring upper respiratory tract illness. 
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Table 2.11 Summary of studies on the risk of Illness and upper respiratory tract illness 
Exercise and the risk of upper respiratory illness 
Author , Exercise Subjects Study period Findings 
Increased risk 
Douglas et al. 1978 Conditioned athletes 61 100ll,M 9weeks t incidence V$ 
with high V02 Max controls 
Nieman et al. 1189a Running< 15km/week 137 66%M 33%F 8weeks t incidence vs 
controls 
Heath et al. 1991 Running> SD 82%M 18%F 46weeks t Incidence vs general 
48&niles!Mlek population 
Risk unchanged 
Osterback et al 1917 Various 3 to 4 X / week 137 $%M E%F 46weeks No difference to 
controls 
Schouten et al. 1918 Various@ 199 46%M 54%F 192weeks No difference to 
>7CDl'letsM'eek (4years) controls 
Decreased risk 
Nieman et al. 1919a Running > 15km/week 136 66%M 33%F 8weeks J. incidence V$ 
controls 
Nieman et al 1990 Walking Emin 5l(J 36 100ll,F 15weeks J.URTI 
week @ El)'l(,max HR symptomatology 
Heath et al. 1991 Running ave. SD 82%M 18%F 46weeks 1,2 events/month YS 
4,7km/day 2,3 events/month In 
general population 
Abbreviations: Mzmale, Fa:female, <"'less than, >=more than, t=increase, J.=decrease, HR=heart rate, mln=minutes, km=kllometres, 
URTl=upper resplratcxy tract mness. 
In contrast Douglas et al. (1978) compared 61 conditioned athletes N02 max 55-76ml/kg/mln) to 126 
unconditioned cadets N02 max 30-54ml/kg/min) as to the frequency and severity of upper respiratory 
tract illness over a 9 week period. This study found that the high exercise group experienced upper 
respiratory tract illness more frequently than the control group. 
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Osterback et al. (1987) studied the incidence of upper respiratory illness over a 12 month period in 
children (mean age 12,7 years), who actively participated in gymnastics, swimming and ice hockey. No 
differences in the Incidence of URTI were found between the sports and control groups. They 
concluded that sports participation does not seem to have a preventative effect on the occurrence of 
upper respiratory tract illness in children. The Amsterdam Growth and Health Study in 1988 confirmed 
these results as reported by Schouten et al. (1988). The exercising group was classed as expending 
more than 700 mets/week. The study found that an Increased level of habitual physical activity in a 
young and normal population does not show lower incidence and shorter duration of upper respiratory 
tract symptoms. 
Two further studies indicated a positive effect of exercise on upper respiratory illness. Nieman et al. 
(1990) trained 36 mildly obese and sedentary women over a 15 week period by walking for 45 minutes 
at 60% of maximum heart rate five times a week. Compared to a control group the exercised group 
reported significantly fewer days with upper respiratory tract illness symptoms during the 15 week 
period. 
In the Heath et al. (1991) study on a group of 530 runners over a period of one year the incidence of 
upper respiratory tract illness was investigated and the total annual mileage was related to the 
incidence of upper respiratory tract illness. The subjects ran an average of 4. 7 miles per day, but a 
summary of the total mileage done in the year showed an increased odds ratio (the predicted number 
of bouts of upper respiratory tract illness for the year) for contracting 1,.1pper respiratory tract illness with 
an increase in the total mileage (Table 2.12). The average incidence of upper respiratory tract sickness 
events in this study was 2.1 events per year. (Heath et al. 1991). This incidence is lower when 
compared to the Incidence of upper respiratory tract illness in the general population of 2.3 events per 
year (Badger et al. 1953). 
Table 2.12 Summary of total miles run per year and the odds ratto for contracting upper 
respiratory tract illness in a year (Heath et al. 1991). 





> 1388 2.0 
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Contrary to anecdotal evidence, some studies listed in Table 2.11 indicate no difference in the risk of 
acquiring upper respiratory tract illness when comparing athletes to controls and one study shows an 
increase in the risk when associated with mild to moderate levels of exercise. With more strenuous 
levels of exercise one study shows a decrease, while two studies show an increase in the Incidence of 
upper respiratory tract illness. In summary it appears that mild forms of exercise do not result in an 
increase in upper respiratory tract illness and may even be beneficial in protecting against the illne$S, 
but as exercise intensity increases, so does the risk of acquiring upper respiratory tract illness. 
From the summary in Table 2.11 it is clear that there are conflicting reports on the risk of acquiring 
upper respiratory illness whilst exercising. However, the J-shaped curve proposed by Nieman (1994) 
seems to reflect the findings of most studies, that regular moderate exercise is beneficial in preventing 
URTI and strenuous exercise increases illness risk. 
2.3.2 THE EFFECT OF REGULAR EXERCISE TRAINING ON THE RISK OF UPPER 
RESPIRATORY TRACT ILLNESS. 
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In general, athletes believe that regular physical activity protects them against upper respiratory illness 
or that regular exercise training might shorten the period of illness (Nash 1986). A study by Nieman et 
al. 1998 supports the belief that regular exercise might shorten the period of illness. In this study obese 
women were exercised with five 45 minute walking sessions per week at 60% to 75% of their maximum 
heart rate. The results indicated that the number of days with symptoms of upper respiratory tract 
infection was reduced to 5.6 in the exercise groups compared to 9.4 in the non-exercise control groups. 
However there is little scientific evidence to support the belief that regular exercise might decrease in 
the risk of contracting upper respiratory tract illness. Results of studies to this effect are summarised in 
Table 2.11 where the studies of Schouten et al. (1988), Nieman et al. (1990) and Osterback et al. 
(1987) are significant. 
The Amsterdam growth and health study of Schouten (1988) studied the relationship between regular 
physical activity and upper respiratory infections in a normal population of young men and women 
(n=199). Subjects were 92 men and 107 women (age 20 to 23 years) and they were followed up for 4 
years. The subjects participated in various sports and activities and the intensity of activity was reported 
in metabolic equivalent (MET) which is the ratio between metabolic rate during steady-state work and 
the basal metabolic rate of the subjects. Three levels of activity were identified, 4-7 METS for low 
intensity physical activities, 7-10 METS for medium intensity activities and 10 METS or more for high 
intensity activities. Furthermore, a group was identified who spent more than 700 METS per week and 
this group was divided into an outdoor and an indoor group to examine the possible influence of 
exercise in a cold environment. The incidence rates for upper respiratory illness in all the study groups 
were similar to the incidence rates among the general population reported by general practitioners in 
the Netherlands. The duration of upper respiratory tract symptoms was not related to the levels of 
physical activity in the study groups. The study also found that sports outdoor in the winter season at an 
intensity level of more than 700 METS did not increase the incidence of upper respiratory tract illness 
symptoms compared with indoor sports {Schouten et al. 1988). 
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The incidence of respiratory tract infections in children (mean age 12,7 years), who participated in 
regular, supervised training in gymnastics (n=16), swimming (n=14) and ice hockey (n=32) was also 
reported for a 12 month period (Osterback et al. 1987). The children had been training regularly three 
to four times a week for four years. They were compared to a control group of children (n=75) who did 
not exercise regularty. All the children contracted on average 2,8 upper respiratory tract infections 
during the 12 months. In the incidence of respiratory infections there was no significant difference 
between the sports groups and control groups of children. There was also no significant difference 
between the different types of sports in the incidence of respiratory infections. (Osterback et al. 1987). 
In this study, there was no indication of the intensity or duration of exercise and these results can thus 
be viewed as a general observation. 
Table 2.13 Summary of studies on the incidence of upper respiratory tract illness with 
regular exercise. 
Regular exercise and the incidence of upper respiratory illness 
Reference Physical activity Duration Incidence 
Badger et al. 1163 General population - 2,3 events/year 
Osterbach et al. 1987 Gymnastics, swimming, ice- 12months 2,6 events/year 
hockey Equal to control group 
Schouten et al. 1988 Various sports with intensity 4years Equal to general population 
of> 700 METS/week 
Heath et al.1991 Running ave. 4,7 miles/day 12 months 2, 1 events/year 
In summary, there is evidence that regular participation In exercise decreases the risk of upper 
respiratory illness in athletes. Where Schouten (1988) and Osterbach (1987) found their athletes to be 
no different to the general population, Heath et al. (1992) reported a slight decrease in the upper 
respiratory tract illness events over one year (Table 2.13). However, from studies by Nieman et al. 
(1989a), Douglas et al. (1978) and Heath et al. (1992) there is evidence that increase in intensity and 
frequency of exercise may be responsible for an increase in the risk for acquiring upper respiratory tract 
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illness. There is also evidence that regular exercise decreases the period of illness when compared to 
the sedentary population {Nieman et al. 1998). 
2.3.3 SUMMARY AND CONCLUSIONS. 
Present evidence seems to indicate that an increase in training results in an increase in psychological 
as well as physical stress. This leads to changes In the natural as well as acquired immune processes 
that have the effect of suppressing the immune response. This in turn increases the risk for acquiring 
upper respiratory tract illness. If this is true, exercise must then be a risk factor for acquiring upper 
respiratory tract illness and athletes must then have a higher incidence of upper respiratory tract illness 
events over a period when compared to the general population. Studies to this effect have some 
conflicting results. Where most studies indicate that exercise leads to an increased risk of contracting 
upper respiratory tract illness, some show a decrease or no difference in risk and incidence. In 
analysing these studies, the results seem to indicate that the risk of acquiring upper respiratory tract 
illness is related to the intensity and duration of the exercise. 
A summary of the evidence thus seems to indicate that regular participation in mild to moderate 
exercise offers protection against contracting upper respiratory tract illness. Athletes who train at more 
strenuous levels and with longer duration seem to be more at risk for acquiring URTI, as is explained in 
the J-shaped curve for the risk of contracting URTI {Nieman 1994). A possible explanation for some 
studies which found that strenuous exercisers have a benefit in that they have slightly fewer illnesses 
over a given period when compared to the general population, might be due to the athletes actively 
selecting to avoid situations where they could become infected. The slight decrease in incidence of 
upper respiratory illness might thU$ not be due to the exercise per se. 




The effect of an upper respiratory tract illness on exercise performance in the recovery period has not 
been well studied and Is hence poorly understood. Athletes report that there is a decline in exercise 
performance post-illness . This effect, If present, may be the result of detraining during the illness as 
upper respiratory tract illness can force an athlete out of training for periods ranging from a few days to 
a few weeks. In addition, the decrease in performance may be due to additional pathological effects of 
the illness itself (Nash 1986). 
Despite the fact that an URTI occurs commonly, particularly in highly trained athletes (Nieman 1994), it 
is not known how long it might take the athlete to regain the level of performance after such an illness. 
This review will examine evidence relating to 1) the degree to which an athlete's fitness declines during 
the URTI, 2) the time period necessary for recovery and return to pre-illness performance levels. Both 
animal and human studies pertinent to these issues will be reviewed. 
2.4.2 ANIMAL STUDIES. 
Friman et al. (1991) observed changes in metabolic parameters and exercise performance rats Infected 
with bacteria. In order to determine whether shortages in fuel reserves or alterations in energy substrate 
utilization might contribute to a decrease In performance during bacterial infection, oxygen 
consumption, lipid and carbohydrate metabolism were measured during swimming exercise to 
exhaustion in these infected rats. 
All the Infected rats were febrile and experienced a further Increase In body temperature during 
exercise. Compared to pre-infection recordings there was an increase In oxygen consumption and 60% 
decrease in swimming performance (time to exhaustion) post-infection. Glycogen stores and plasma 
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free fatty acid levels were decreased, while plasma insulin, glucagon and ketone levels were increased 
(Friman et al. 1991). 
The changes in lipid and carbohydrate metabolism suggested that the carbohydrate stores become 
reduced during the febrile illness and that fat is increasingly utilised during exercise. The authors 
concluded that there was a probable deranged oxidative metabolic capacity of the exercising muscles 
during the infective period and they speculated that this was evident to be the cause for the impaired 
exercise performance. Raised serum lactate concentrations during exercise indicated increased 
reliance on oxygen independent metabolism (Friman et al. 1991). 
In another study, llback et al. (1989) investigated similar metabolic and exercise changes during illness. 
Similar methods were used with Streptococcus pneumonlae infected rats and the same metabolic 
testing was done. The results were similar to the study of Friman et al. (1991) and also indicated that 
there was a shift from carbohydrate metabolism toward fat metabolism with exercise during the febrile 
illness. 
These studies illustrate that there is an apparent switch from glycogen to fat metabolism during illness 
and that this metabolic change is concurrent with a decrease in physical performance. This however is 
not proof that the poor physical performance is due to this metabolic change. To date no animal studies 
have been done during the recovery period following the illness. 
2.4.3 HUMAN STUDIES. 
A number of studies have been conducted in humans to investigate the effect of febrile illness on 
physical exercise performance, cardio-pulmonary function, metabolism and skeletal muscle 
parameters. 
In a case study an elite cyclist underwent repeated physiological assessments over a 15 month period 
whilst training for a 100km national event. During this period the cyclist developed fever and reported a 
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decrease in performance. Subsequent testing indicated raised antibodies to Coxsackie virus (titres 
>300) (Jakeman 1993). Exercise testing was resumed one week after body temperature returned to 
normal. During prolonged submaximal exercise the cyclist had an increase in heart rate and perceived 
exertion with a decrease in total exercise time (pre-illness = 180 minutes, post-illness = 150 minutes). It 
was found that the respiratory exchange ratio (RER) decreased during exercise indicating a higher 
percentage of fat oxidation. Blood lactate concentrations were higher at all levels of submaximal 
exercise and this was interpreted as an increase in oxygen independent metabolism. The increase in 
oxygen independent glycolysis could be due to a greater use of carbohydrate during the infectious 
illness, which would then rapidly deplete the carbohydrate stores leading to increased reliance on lipid 
metabolism. The subject completed six stages of a graded exercise protocol pre-illness. Following the 
first week post infection the subject could only complete four stages of the protocol and five of the six 
stages thereafter. There was a pronounced increase in heart rate at all levels of exercise. The author 
speculates that the increase in heart rate could be due to myocardltis or pericarditis resulting from the 
infection (Table 2.14). Clinical electro - cardiographic studies were done during exercise but did not 
however reveal any abnormalities in the subject. 
Table 2.14 
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Summary of results from studies on the effects of upper respiratory tract illness 
on exercise performance variables. 
Physiological e~cts of upper respiratory tract illness 
Reference Parameters tested Results 
During Illness Post Illness 
Jakeman 1993 V02 max (litres/min) t 
HR max (beats/min) t t 
RER (units) t 





Daniels et al. 1965 HR max (beats/min) t N 
Muscle Bbength (1sometric and .j. N 
dynamic conbactions) 
SUbmax. walking (graded 
treadmill tBSt) .j. N 
Friman et al. 1985 Muscle enzymes N N 
Muscle ullrastruclure N N 
Stroke volume .j. .j. 
Ca~iac output N Due to increased HR .j. 
Friman1977b Muacle strength (lsomelric .j. N 
contractions) 
Friman et al. 1977• NMT (single fibre EMG) .j. N 
Astrom et al. 1 g79 Muscle enzymes .j. 
Muscle ultras1ruclun, Abn. 
Breven 1962 HV(mQ .j. 
HR max (beals/min) t 









Abbreviations to Table 2.14: V02 Max= maximal oxygen uptake In ml/kg/min, HR max= maximal heart rate achieved during testing, 
RER z respiratory exchange ratio, RPE = rate of perceived exertion on the Borg scale, NMT = neuromuscular transmission, HV = 
heart volume, VC = vital capacity, FRC = functional residual capacity, TC = total lung capacity, FEV1 = forced expiratory volume in 
one second, DC = diffusion capacity, -l. = decrease, t = increase, N = Normal. 
These observations concur with the results of the studies in Infected rats where carbohydrate stores 
seem to rapidly become reduced with an increased utilisation of fat metabolism. The increase in blood 
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lactate during and after illness might be due to Impaired oxidative capacity of the muscle which then 
requires a greater contribution from oxygen independent metabolism and could result in muscle 
acidosis which might be one of the reasons for fatigue. It might be significant that the subject was 
unable to complete a graded exercise test ~>ne week after fever had subsided. This may be due to 
metabolic inhibition and/or physiological abnormalities due to the illness and/or may be ascribed to a 
central protective mechanism to spare vital functions from being damaged due to excessive exercise in 
a state of illness. 
At the United States Army Research Institute exercise parametens were tested before, during and after 
an infective process with the sandfly fever virus. The disease is characterised by the rapid onset of flu-
like symptoms. Nine subjects volunteered, seven were inoculated with the virus and two were used as 
controls and inoculated with saline. Submaximal walking on a treadmill and muscle strength tests were 
performed before inoculation, 4 days after inoculation and 7 days after fever had subsided. The study 
found that during pyrexia measurements of isometric muscle strength were decreased and submaximal 
work performance was limited In some individuals. During a submaximal walking test in the febrile state, 
three subjects were unable (or unwilling) to complete the test. In the early convalescent stage after the 
fever had subsided, the submaximal exercise performance and muscle strength returned to near 
normal (Daniels et al. 1985) (Table 2.14). 
It was noted that there seemed a marked unwillingness of subjects to perform some types of exercise 
during pyrexia and they seemed to voluntarily terminate the activity. This might indicate a central 
defence mechanism to protect against Injury of vital organs due to exertion during febrile illness. It is 
significant that the muscle strength and submaximal exercise performance returned to normal rapidly, 
once the fever subsided. This might indicate that the fever itself contributed to the decrease in 
performance 
In the above mentioned study by Daniels et al. (1985), Friman et al. (1985) participated to investigate 
the effect of the sandfly fever viral infection on muscle enzymes, muscle ultrastructure, cardiac output 
and stroke volume. The muscle and serum enzymes recorded were creatinine kinase (CK), lactate 
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dehydrogenase (LDH), triose phosphate dehydrogenase, citrate synthase and lysosomal enzymes. 
None of the enzymes changed notably during the illness nor during the post febrile phase. No 
abnormalities were found on muscle biopsies in the ultrastructure of skeletal muscle. It was 
documented that cardiac output was maintained at pre-illness levels during the febrile illness although 
the stroke volume was decreased. After the fever had subsided the cardiac output decreased. The 
maintenance of cardiac output during the illness was as a result of the increase in the heart rate. The 
lower cardiac output after the fever corresponded to a slower pulse rate and the smaller stroke volume 
(friman et al. 1965) (Table 2.14). 
In this study there were no significant alterations in the activities of oxidative or glycolytic enzymes. This 
could support the hypothesis that oxygen independent metabolism during febrile illness increases. 
Although the cardiac output and stroke volumes were decreased, a tachycardia seemed to adequately 
compensate for the cardiac output. Decreases in exercise performance following upper respiratory tract 
illness might occur if the increase in heart rate reaches a stage where it is ineffective in compensating 
for a reduced stroke volume. 
Isometric muscle strength was measured by Friman (1977b) who tested a group of 39 patients suffering 
from various infectious diseases of viral and bacterial origin. A control group consisted of healthy 
subjects that were confined to bed for the same period of time as the patients. Recordings were made 
immediately after the fever subsided, at one month post fever and at 4 months post fever. Muscle 
strength was found to be decreased in the patients once the fever had subsided compared to the 
control subjects, but were similar compared to the controls, one and four months afterwards (Table 
2.14). 
In another study by the same author (Friman et al. 1977a) neuromuscular transmission during febrile 
Illness due to influenza or echovirus infection was measured in 14 patients with influenza and 9 patients 
with mumps. Single fibre electromyography (EMG) was performed during the febrile period, 
immediately after the fever and 2 weeks later. Mildly abnormal transmission characteristics during the 
acute phase of the disease were documented. The authors concluded that abnormal transmission is 
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part of the disease process in the muscle and this might explain muscle weakness experienced during 
the febrile phase of illness (Table 2.14). 
Enzyme activities and muscle ultrastructure changes were measured by Astrom et al. (1976) during 
viral and mycoplasma infection. Thirteen patients were studied and they were compared to eight 
healthy controls who were confined to bed for time periods similar to the confinement to bed of the 
patients. It was documented that the activities of glyceraldehyde-3-phosphate dehydrogenase (GPO), 
lactate dehydrogenase (LOH), citrate synthetase (CS) and cytochrome oxydase (cytox) were lower in 
the skeletal muscle of patients than in the muscle of healthy control subjects. These changes were 
comparable to patterns documented in progressive muscular dystrophy. The ultrastructure of skeletal 
muscle was also investigated using electron microscopy and some focal deviations abnormalities 
demonstrated. The myofibrils were reduced in diameter, the Z-lines irregular and the mitochondria 
enlarged with inclusion particles. The sarcoplasmic reticulum was distended. These changes were 
consistent with degeneration in the muscle ultrastructure. The enzymatic and ultrastructural changes 
documented in the muscle of infected individuals corresponded to those documented in other 
degenerative muscle diseases. This finding could explain the reduction in performance that athletes 
experience during upper respiratory tract illness (Astrom et al. 1976) (Table 2.14) 
Changes in cardio-pulmonary function were investigated in the post infectious stage of atypical 
pneumonia to determine if recovery per se could have any effect on cardlo-pulmonary function (Breven 
1962). Sixteen cases were investigated during the convalescent stage of atypical pneumonia and were 
compared to 12 controls who were recovering from a non-pulmonary disease. The same parameters of 
heart rate (HR), heart volume (HV), vital lung capacity (VC), functional residual capacity (FRC), total 
lung capacity (TC), forced expiry volume in one second (FEV1) and diffusion capacity (DC) were 
investigated in both the atypical pneumonia and non-pulmonary groups. The results of investigations in 
the non-pulmonary group were similar to parameters previously reported in normal subjects. In the 
atypical pneumonia group there was an increase in HR, but decrease in HV and respiratory parameters 
of VC, FRC, TC, FEV1 and DC. It is speculated that the decrease in the diffusion capacity could be 
caused by a loss of alveoli due to the process of the disease or due to a thickening of the alveolar 
44 
membranes leading to a change in the permeability of the membranes (Breven 1962) (Table 2.14). 
These findings confirm the decreases in cardiac function reported by Friman et al. (1985) as well as 
showing attendant decreases in lung function. This could explain the reluctance of subjects to complete 
exercise protocols following illness. The compromised cardiac and lung functions might lead to 
premature exhaustion with resultant termination of exercise even though the subject might seem 
afebrile with the absence of clinical symptoms. 
A study was conducted by Lloyd et al. (1968) on patients diagnosed as post viral fatigue syndrome 
(myalgic encephalomyelitis) to determine whether their complaints of debilitating fatigue were could be 
measured by a decrease In exercise parameters. These patients fulfilled the diagnostic criteria for the 
condition including subjective fatigueability of muscles, lymphadenopathy and T-cell lymphopenia. 
However, measurements of muscle strength, endurance and recovery were all entirely normal among 
the 20 individuals who reported severe muscle fatigue, suggesting that the fatigue is associated with 
disordered perception of muscle force and effort rather than actual force production (Lloyd et al. 1988). 
This indicates that psychological perception of exhaustion can play a role and thus have a negative 
influence on exercise performance. 
Table 2.15 Summary of data on the effects of upper respiratory illness on exercise 
performance variables. 
Summary of physiologic effects of upper respiratory illness 
Results 
System tested Parameter tested During Post-illness 
illness 
Respiratory Vital capacity (litres) .J, 
Total capacity (litres) t 
FRC (litres) -1,. 
FEV1 (litres) -1,. 
V02 max (ml/kg) .J, 
DC (ml/min/mmHg/m2) .i 
RER (units) 
.i 
Cardiac HR max (beats/min) tt ttN 
Stroke volume .i H 
Cardiac output N .i 
Muscle Muscle strength (Isometric H NN 
and dynamic) 
NMT (single fibre EMG) .i N 
Muscle ultrastructure N-Abn N 
Metabolic Glucose (mmol/litre) -1,. 
Lactate (mmol/litre) t 
Muscle enzymes -l,.N N 
Endurance performance Submax. Walking (graded .i N 
treadmill test) 
RPE (units) t t 
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Abbreviations: V02 Max = maximal oxygen uptake in ml/kg/min, HR max = maxlmal heart rate achieved during testing, RER = 
respiratory exchange ratio, RPE = rate of perceived exertion on the Borg scale, NMT c neuromuscular transmission, HV = heart 
volume, VC = vital capacity, FRC = functional residual capacity, TC = total lung capacity, FEV1 = forced expiratory volume in one 
second, DC = diffusion capacity, -1,. = decrease, t "' increase. N = normal. 
From the results summarised in Table 2.15 it seems clear that cardio-respiratory function is 
compromised during and following upper respiratory tract illness. The decrease in lung function as well 
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as the decrease in diffusion capacity in the lungs may result in inadequate gas transmission during 
exercise and could contribute to decrease In exercise performance following an illness. Furthermore, 
the decrease in cardiac output and stroke volume does not seem to be adequately compensated for by 
the increase in heart rate. This inadequate circulation could lead to premature exhaustion due to 
diminished oxygen supply to the muscles. 
The muscle tests on the other hand indicate abnormalities during the illness which seem to return to 
normal almost immediately after the febrile period of the disease. Decreased serum glucose and 
increased serum lactate concentrations following respiratory tract illness support the reports of a rapid 
depletion of glycogen and subsequent reliance on fat metabolism with exercise during and after the 
illness. It is not clear if this finding might contribute to a decrease in exercise performance as both fat 
and glycogen are adequate sources for energy. The report that exercise parameters tested during 
submaximal walking seems to be normal following upper respiratory illness might Indicate that 
decrease in exercise performance could be limited to strenuous and maximal effort only. Finally the 
increased rate of perceived exertion during and after illness might be as a result of the compromised 
cardio-respiratory functions and changes in metabolic energy utilization. 
It is not known how detraining during the period of illness could influence the decrease In exercise 
performance. Studies measuring the decrease in exercise performance following URT infection have 
never been repeated in the same subjects after a similar detraining period whilst unaffected by URTI. 
2.5 OVERALL SUMMARY AND CONCLUSIONS. 
Upper respiratory tract illness occurs commonly among the general population including the sporting 
community. Although URTI are caused by many microbials, the rhlnovirus is the most common. The 
measures for prevention and management of upper respiratory illness are well documented, but little is 
known of what effect upper respiratory tract illness has on exercise performance. There is evidence that 
the immune response is suppressed for 6 to 24 hours following an acute exercise bout and that this 
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could be a window period during which the athlete is susceptible for contracting URTI. Studies also 
indicate that the intensity and duration of exercise seems to be important in either providing protection 
against URTI or increasing the risk for contracting the illness. Overall evidence seem to indicate 
protection against URTI to the athlete undergoing regular, moderate training and an increased risk of 
contracting URTI during strenuous and prolonged exercise. 
Most authors agree that definite pathological changes take place during upper respiratory tract illness 
and these changes lead to decrease in exercise performance. Decreases in isometric muscle strength, 
dynamic muscle strength and muscle endurance during upper respiratory tract illness have been 
documented in both animal and human studies. During upper respiratory tract Illness studies also 
indicate decreases in cardiac output and physlcal respiratory values as well as some metabolic 
changes. Evidence suggests that the pathology rapidly returns to normal once the fever has 
disappeared. Few studies though have examined the levels of exercise performance during this 
recovery phase, nor whether the decrease in performance is due to the illness itself or the result of 
detraining. 
CHAPTER3 
THE INCIDENCE OF UPPER RESPIRATORY TRACT ILLNESS IN 
DISTANCE RUNNERS - A 45 MONTH FOLLOW UP. 
3.1 INTRODUCTION 
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Adults in the general population contract 2 - 5 upper respiratory tract illness (URTI) events per year with 
an average of 2.3 events per year (Heath et al. 1992). Anecdotal evidence suggests that regular 
exercise training can protect against contracting URTI {Nash 1996; Nieman et al. 1989a; Heath et al. 
1992; Eichner 1993). This observation has been scientifically confirmed for regular, moderate exercise 
but the effect appears to be reversed under conditions of strenuous or acute exercise (Nieman 1994). 
Thus the "J" shaped curve proposed by Nieman (1994) which depicts the risk of URTI in indMduals 
participating in regular, moderate exercise to be less than that of the sedentary population, while those 
engaging in strenuous and acute exercise were at highest risk of acquiring an URTI. 
3.2 AIM OF THE STUDY 
The aim of the study was to closely follow a cohort of athletes over a period of 45 months (May 1992 -
Feb 1996) and to record the incidence and duration of URTI contracted during this time. 
3.3 METHODOLOGY 
3.3.1 SUBJECTS 
For the study, 42 distance runners were recruited from the Empangeni and Richards Bay running clubs 
(KwaZulu-Natal, South Africa) . Each club has an active running population of about 100 individuals, 
from a total population of around 60 000. These athletes were followed over a period of 45 months for 
the development of URTI. Oflhe original 42 athletes recruited, 29 were retained in the study and 13 
dropped out (4 subjects relocated and 9 subjects became untraceable) . 
The athletes were all active endurance runners aged between 25 and 50 years. During the 45 month 
study period they were asked to maintain their levels of fitness for the duration of the study. All the 
subjects were instructed to run between 30 and 50 kilometres per week and to record their weekly 
training schedule on a log sheet (Appendix 4). This criterium of running 30 to 50 kilometres per week 
was calculated from the average distances the subjects reported running at the time of their 
recruitment. The subjects were instructed to run an 8 kilometre time trial weekly and to record these 
times as an indicator of their endurance performance (Appendix 4) . The total training hours of each 
athlete over the two year period was estimated. 
3.3.2 TESTING PROCEDURES 
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Subjects were asked to report any symptoms of an URTI immediately to U1e principle investigator (Deon 
Viljoen). When athletes reported symptoms of URTI they were medically examined to confirm the 
symptoms and signs of URTI using specific criteria (Appendix 5). Symptoms of sore thr at, headache, 
blocked nose, painful chest, coughing , sore eyes and muscle pains were confirmed. The athlete was 
examined for signs of pyrexia, conjunctivitis, pharyngitis, rhinitis, otitis media and bronchitis. Once the 
diagnosis of URTI was confirmed, the athletes took home a standardised form for the daily listing of 
their symptoms and signs (Appendix 6). Once the URTI symptoms and signs had disappeared, the 
athletes reported back to the principle investigator for a medical examination to confirm that they have 
recovered from the illness. The number of URTI events per 1000 training hours was calculated as the 
incidence of URTI in this group. 
When this study commenced, the prolonged time it took to collect the data was not anticipated. It was 
initially expected that enough subjects should report with clinical illnes~ and thus be tested within six to 
eight months. The limited number of subjects and the inclusion/exclusion criteria eventually dictated a 
period of 45 months. Due to this extended time subject compliance for diligent data recordings of 
distances run and time trial times were poor. When subjects reported an URTI, the data for weekly 
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distances run and time trial times for four weeks prior to illness were recorded. This data was correlated 
with their entries on the study forms (Appendix 4), their own logbooks and the logs on time trial times 
kept by their clubs. Following illness the subjects were allowed a period of more than 3 months to 
regain their fitness levels. During the four weeks prior to detraining the subjects were instructed to run 
similar weekly distances as recorded prior to falling ill. Their time trial times were compared to the times 
they ran for the four weeks prior to illness to ensure that they had achieved the same level of fitness. 
The inclusion criterium for URTI was a period where symptoms lasted for five days or more and the 
exclusion criterium was an illness with symptoms lasting less than 5 days. These criteria were decided 
upon to maximise the chance of upper respiratory tract illness resulting from infection. It was also 
thought that URTI symptoms lasting less than 5 days might be due to mechanical effects of strenuous 
exercise or long endurance events and not due to infection. 
3.3.3 RESULTS 
As depicted in Figure 3.1, in the group of 29 athletes there were 22 reports of upper respiratory tract 
illness (76%) of which 12 (55%) lasted longer than 5 days which complied with the URTI inclusion 
criterium for clinical illness (Cl). The other 1 O subjects (45%} had symptoms for only 2 to 3 days and all 
these episodes immediately followed their participation in a long distance endurance event. These 
subjects did not comply with the URTI inclusion criterium and had mild illness (Ml). Seven subjects 
(24%) did not report URTI symptoms during the 45 month period and thus had no illness (NI). 
The twelve subjects out of the 29 with clinically confirmed illness (Cl) , reported URTI lasting 5 days or 
longer over a period of forty five months. When projected into four years, 3.2 subjects (12%} ( ut of the 
study group experienced clinical upper respiratory tract infections per annum, which is an odds ratio 
(incidence of upper respiratory tract illness in one year} of 1.03 upper respiratory tract infections per 
year. 
Ten of 29 subjects reported URTI of less than three days duration and occurring directly following an 
endurance event. The inclusion criteria for an URTI was a minimum of five days illness. These events 
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were thus excluded from the study. 
The incidence of URTI In 1000 hours of training was estimated and calculated as follows. Athletes in 
the study trained for 30 to 50 km/week (average of 40 km/week) at an average speed of 5min/km. 
During the study period of 45 months each athlete ran on average 600 hours. The 29 athletes 
participating in the study ran an estimated total of 17 400 hours in the 45 months. The total incidence for 
URTI (n = 22) per 1000 training hours was 1.26. The incidence for the athletes with mild URTI with the 
symptomatic period being less than 5 days (n = 10) is 0.58. The incidence for athletes with moderate 
URTI with the symptomatic period more than 5 days (n = 12) is 0.69. 






Recruited (n = 42) 
~ 
URTI-76% 
(n = 22) 
100% 
(n = IO) 
29 Athletes 
100% 
No illness (NI) - 24% 
(n = 7) 
0,69 1------------- Clinically co11fim1ed illness (Cl) - 55% 
(n = 12) 
Figure 3.1 Flo diagram of experimental group. 
(NI = no illness. Ml = mild illness. Cl = clinically confirmed illness.) 
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3.4 DISCUSSION 
In this study, the odds ratio for a runner running an average of 1920km per year to acquire an upper 
respiratory tract illness is 1.03 per year. This correlates well with Heath et al. (1991), who found that 
athletes running less than 782km per year had an odds ratio of 1.0 and when they ran 782 to 1392km 
per year their odds ratio was 1.7. These ratio's are much lower when compared to the general 
sedentary population where an odds ratio of 2.3 for contracting upper respiratory tract illness per year 
has been documented (Badger et al. 1953). 
It therefore appears that running 1920km per year affords protection against acquiring upper respiratory 
tract illness. However, the improved odds ratio might also be due to the athletes being a selected group 
who are highly motivated and practice preventative measures against contracting upper respiratory tract 
illness. For example, they may avoid crowded places and wash their hands and not touch their faces for 
fear of contracting the illness. Athletes are a self-selected group and cannot be compared to the 
general population. Other studies have also documented regular exercise training does not necessarily 
afford protection against upper respiratory tract illness (Osterback et al. 1987; Schouten et al 1988; 
Nieman et al. 1990). 
It has been shown that exercise promotes an increase in free radicals. Free radicals can alter and 
inactivate enzyme complexes and damage cells, damage DNA and RNA and promote mutations and 
cancer (Kanter 1998). Thus free radicals can be important in the initiation of exercise-induced muscle 
damage and in the initiation and propagation of the subsequent acute muscle inflammatory response. 
Antioxidants have the potential to limit muscle oxidative stress during the postexercise period, but direct 
evidence for their role is limited (Tiidus 1998). There is also evidence that physical training results in 
increased activity of several major antioxidant enzymes and overall overall antioxidant status of the 
trained individual (Dekkers et al. 1996). This study did not record the intake of supplements by the 
athletes and the effect of free radicals due to disease and/or training is not known. 
The symptoms of URTI which developed in 10 athletes (45%) directly followed their participation in a 
strenuous endurance event. These symptoms could possibly be attributed to the event itself rather than 
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to infection. This finding would correlate with a study by Brenner et al. (1994) who showed that faster 
runners complained more frequently of upper respiratory tract illness symptoms. The 10 athletes in this 
study who reported symptoms of URTI following participation in strenuous endurance events, were ill 
for a maximum of three days. This period of illness is typically too short to indicate an infection be<tause 
it is well accepted that URTI illness due to infection will last for longer than 5 days (Knight 1977). 
Studies investigating the immune system during and after strenuous events, indicate that cellular 
elements responsible for the immune response are depressed immediately following the exercise 
(Eichner 1993). This suppression of immunological parameters following strenuous exercise might 
manifest with symptoms of URTI for a limited period and thus might explain the short term symptoms of 
URTI for a few days following these events. Furthermore, there is evidence that regular exercise 
stimulates the immune response (Nieman et al. 1990) and thus protects against URTI (Heath et al. 
1992). This might also protect against acquiring URTI for longer than 3 days following strenuous 
exercise. 
A limitation of this study is the absence of a control group of sedentary subjects. Such a group would 
have enabled the study to compare the incidence of URTI in a sedentary population to the incidence of 
URTI in a population of trained athletes over a period of 45 months. Furthermore valuable data would 
have been available to indicate the periods of symptomatic illness in the sedentary group compared to 
the exercise group. It is also possible that the intensity and detail of the exercise protocols might have 
been responsible for some athletes not making themselves available for this study, thus the small 
number of subjects. 
3.5 SUMMARY 
This study indicates that runners who perform regular, moderate, endurance exercise have a low odds 
ratio for contracting upper respiratory tract illness. Endurance exercise ' ~ining ~:loes not increase the 
incidence of upper respiratory tract illness, and may even decrease the risk for acquiring the illness. 
This might be due to a self-selection process with regard to the testing programme as well behaviours 
which minimise the risk of infection. Participants in this study were generally well informed of the 
54 
methods of transmission of disease and protect themselves from being contaminated and infected. This 
finding means that these athletes are a selected group and cannot be compared to the general 
population. Furthermore, simpler protocols with less variables and less frequent testing might have 
resulted in more athletes becoming available for testing. 
CHAPTER4 
THE EFFECTS OF UPPER RESPIRATORY TRACT ILLNESS 
ON EXERCISE PERFORMANCE IN THE RECOVERY PERIOD 
4.1 INTRODUCTION 
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Anecdotal evidence suggests that there is a decrease in exercise performance in the days or weeks 
following an upper respiratory tract illness. Evidence from a limited number of scientific studies indicate 
that the pathological changes that occur during upper respiratory tract illness may be responsible for 
the decrease in exercise performance (Breven 1962; Astrom et al. 1976; Friman 1976; Friman et al. 
1977a; Friman et al. 1985; Nash 1986; Friman et al. 1991). However, the extent and duration of any 
decreases in perfonnance is unknown, as is the degree to which detraining contributes to this post-
illness decline. This study was designed to answer the question of what the extent of decline in exercise 
performance is following URTI and how much of the decline is due to the illness and how much is due 
to the detraining alone. 
4.2 MATERIALS AND METHODS 
This is a cohort prospective clinical trial of 45 months duration to investigate the effect of URTI and 
detraining alone on exercise performance. 
4.2.1 SUBJECTS 
The athletes were selected and tested following an URTI that complied with the inclusion/exclusion 
criteria for this study. 
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4.2.2 TESTING PROCEDURES 
All laboratory tests were conducted at the laboratory of the Department of Human Movement Sciences 
at the University of Zululand. 
Over a period of two years, baseline tests were performed on 42 athletes after which they were 
monitored for the development of a URTI. Initially three athletes were recruited for pilot studies and the 
protocol was tested, designed to avoid errors and to test the practical feasibility of the protocol. The 
protocol allowed for baseline tests to be performed on the subjects and these tests were used to 
calculate the workload for follow-up testing. 
4.2.2.1 PRE TRIAL SCREENING 
The subjects chosen for this study completed a medical questionnaire {Appendix 2) and also signed a 
consent and indemnity form (Appendix 1). A full medical examination was performed on all the athletes 
at the time of recruitment following prescribed parameters (Appendix 3). 
Base-line tests were performed on the subjects and their maximum aerobic capacities were measured 
(Appendix 7). On Appendix 7 the time on the treadmill was recorded in the left column and the 
corresponding treadmill speed in the right column. When this data was compared to the respiratory 
parameters recorded with the Oxycon apparatus, it was possible to calculate at what treadmill speed 
the subject achieved his V02 max. From this data the treadmill speed at a V02 of 70% of max could be 
calculated and this 70%V02 max was used in the actual testing protocol as outlined in section 4.2.3.2. 
lsokinetic muscle strength and muscle endurance was also measured. The exact testing procedures 
are outlined in paragraphs 4.2.3.1. and 4.2.3.2. The maximum aerobic capacities were used to 
calculate 70% of their workload. The maximum oxygen uptake (V02 peak in ml/kg/min) was measured 
at the point of maximal effort and 70% of this parameter was calculated. This was the intensity that 
testing would be performed at when athletes contracted an upper respiratory tract illness. 
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4.2.2.2 DIAGNOSIS AND MANAGEMENT OF URTI 
Once an athlete developed an upper respiratory tract Illness the athlete reported to the investigating 
doctor to confirm the clinical diagnosis. Medical examinations were conducted to confirm that the signs 
were consistent with upper respiratory tract illness and not due to localised illness such as a suppurative 
tonsillitis. Only subjects with periods of illness lasting 5 days and long(Jr were admitted to the study 
(Table 4.1 ). Some subjects reported upper respiratory tract illness symptoms immediately after 
completing endurance races where the symptoms only lasted for 2 to 3 days. 
Table 4.1 Criteria for admission to the study 
Inclusion Exclusion 
General clinical symptoms Localised infection 
and signs of URTI: 
Symptoms: Sore throat, headache, 
blocked nose, painful chest, cough, 
sore eyes, muscle pains. 
Signs: Pyrexla, conjunctivitis, 
pharyngitis, rhinitis, otitis media, 
rhonchlt, wheeze. 
Illness lasting > 5 days Illness lasting< 5 days 
Subjects were instructed not to take any medication on commencement of the illness prior to the 
medical examination. This was to prevent treatment from masking any symptoms. Once the diagnosis 
was established, symptomatic treatment consisting of antihistamines, cough syrup and analgesics were 
allowed during the period of illness. Medication was discontinued 24 hours before the final medical 
examination after all the symptoms subsided and during the testing period after the illness. 
During the period of illness, the subject recorded the symptoms on a daily symptom chart (Appendix 6). 
During the time of illness no training was allowed. Strict instructions were given to athletes so that they 
accurately recorded data on the symptom chart. Symptoms were graded for severity on a scale from O 
to +++ with O - no symptoms, + - slight symptoms, ++ - mild symptoms and +++ - severe symptoms. 
Patients were requested to record their oral temperature and resting pulse rate each morning on 
waking up. The temperature was taken with an oral thermometer that was held under the tongue for 
two minutes. The pulse rate was measured by palpating the carotid artery and timed on a wrist watch 
for 60 seconds. Once all clinical symptoms had disappeared, the subjects reported to the doctor to 
confirm the end point of the illness. The end point of the Illness was therefore defined as the point 
where all clinical symptoms and signs were absent and performance testing could commence. 
4.2.3 PERFORMANCE TESTING FOLLOWING URTI 
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The athletes were tested within 24 hours from the designated end point of Illness (Day 0). lsokinetic 
strength and muscular endurance were first tested. In addition, subjects performed an exercise test at 
70% of their maximum aerobic workload for 40 minutes after which the effort was incrementally 
Increased to exhaustion. These tests were repeated every two days over a period of six days following 
the illness. No exercise other than the prescribed tests was allowed during the six days of testing. These 
repeat tests will be referred to as Day 2, Day 4 and Day 6 after illness. 
4.2.3.1 MUSCLE STRENGTH AND ENDURANCE TESTING 
Muscle strength and endurance of the quadriceps and hamstring muscle groups of the right leg were 
tested using an Akron isokinetic unit (Akron, Great Britain). The apparatus was set to accommodate the 
leg length of each individual according to the published manual. The right leg of the subject was 
positioned so the knee was free to move in flexion and extension. The right thigh was firmly strapped to 
the seat of the machine to prevent movement during the test. The right ankle was strapped to the lever 
arm of the Akron and the lever was set to ensure that the arc of movement was smooth for the leg, and 
that there was no friction during movement between the leg and the lever. The athlete was allowed to 
hold onto the sides of the seat during the tests. 
Once the athlete was secured in the seated position the angle was set to zero with the knee in the fully 
extended position. The athlete was then assisted in familiarising himself with the operation of the 
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apparatus. Following this the subject was allowed to perform warming up exercises by extending and 
flexing his leg for 20 seconds with the speed set at 180 degrees/second. A compulsory rest period of 5 
minutes was then allowed. 
The subject was first tested for muscle endurance. The right knee was extended and flexed with 
maximal effort for 35 seconds at 180 degrees/second. The subject was then rested for ten minutes 
before the test for muscle strength was commenced. In this test the right knee was extended and flexed 
with maximal effort for 10 seconds at 60 degrees/second and the data for these tests were recorded by 
using the Akron computer program. During the tests the subjects were continuously motivated verbally 
to deliver their maximal performance. 
The parameters of muscle strength were recorded during the 10 seconds of maximal repetitive flexion 
and extension of the right knee at a speed of60 degrees/second. Muscle strength was measured in 
Joules, power was measured in Watts and flexion and extension torque to body weight In Newton 
meters/kg. 
The muscle endurance was recorded as the total work done (In Joules) during the full period of 35 
seconds of repetitive flexion and extension of the knee at a speed of 180 degrees/second. 
The protocols for muscle strength and endurance was used for the baseline tests and the format was 
kept exactly the same for the tests following the illness period as well as the tests following the 
detraining period. All the subjects on the study had performed baseline tests. During these tests they 
were faf!1iliarized with all the apparatus and study protocols. 
4.2.3.2 ENDURANCE PERFORMANCE TESTING 
The test for aerobic endurance performance was performed 1 O minutes after the muscle endurance 
and strength tests. Endurance performance was tested with the subject running on a treadmill 
(Powerjog E10- Powerjog, Great Britain) and coupled to a respiratory analysis system (Oxycon Sygma 
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- Mijnhardt, Holland). The treadmill was set at zero elevation. Core te·mperature was continuously 
monitored by a recto thermo coupler (YSI - part of Oxycon Sygma apparatus with a sensor that is 
inserted in the rectum and connected to the apparatus by a wire lead) and recorded by the resident 
computer program. The rectal temperature probe was kept in place by taping the lead to the gluteal 
area. The respiratory analysis system consisted of a mouthpiece, exhaust controller and wide diameter 
tube connected to the Oxygon Sygma apparatus which is a free standing unit housing the respiratory 
analysis apparatus and the computer hardware. The respiratory variables were captured by the resident 
computer program. Prior to testing the Oxycon system was calibrated in a standard fashion using 0% 
oxygen, 4,9% carbon dioxide and air volume. During the closed circuit breathing the subjects nose was 
clamped to prevent nasal breathing. A twelve lead ECG (Cardiovit At6 - Schiller, Switzerland) was used 
to monitor the electrocardiogram during the first test on day O following illness. Before commencing the 
test each subject was familiarised with the apparatus and the testing procedure. 
During baseline testing (Appendix 7), the subject first stood on the treadmill at rest for one minute. The 
treadmill was then started and accelerated to 3 kilometres per hour (kph) over one minute. The subject 
then walked at this speed for the next two minutes. The treadmill speed was once more increased to 7 
kph over one minute at which speed the subject jogged for three minutes. The treadmill speed was 
increased at one kph every minute until the athlete reached exhaustion. During the test the athlete was 
verbally encouraged to complete the test to exhaustion. 
A submaximal treadmill exercise test was performed and the data from the baseline test was used to 
calculate the workload required to achieve 70% of maximal effort. For this test the athlete stood on the 
treadmill for one minute during which the resting parameters were recorded. The treadmill was started 
and incrementally accelerated over five minutes to reach the calculated speed to achieve 70% of 
maximal effort. The subject then ran et this speed for 40 minutes after which the treadmill speed was 
increased by 1 kph every minute until the subject reached ultimate exhaustion. The treadmill speed was 
then rapidly decreased to a walking speed of 3 kph and this was maintained for two minutes during 
which the recovery parameters were recorded. Respiratory parameters were recorded in the first 5 
minutes and the last 5 minutes of submaximal exercise, and continuously during the exercise to 
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exhaustion. During the test the athlete was verbally encouraged to perform at maximal capacity. 
For the endurance test, the Oxycon system measured the 0/02) oxygen in ml/kg/min, the 0/COi) 
carbon dioxide in ml/kg/min and respiratory frequency as breaths per minute (RF). The system 
calculated the respiratory quotient (RQ), metabolic units (METS) and the volume breathed in and out 
0J'e) in litres per minute. The measured and calculated parameters were recorded every minute during 
the test. 
During the endurance testing the rate of perceived exertion (RPE) was included in the protocol. This 
data was incompletely recorded and thus excluded in this report. 
4.2.4 RETRAINING PERIOD 
Following the period of illness and the subsequent performance tests the athlete was encouraged to 
commence normal training in order to regain the same state of conditioning prior to developing the 
illness. This was conducted by adhering to a prescribed exercise schedule until the athlete was able to 
run 30 to 50 km per week, corresponding to the distance run prior to illness. Weekly 8 km time trial 
times were again recorded. The time period allowed for the athletes to regain their fitness In all cases 
exceeded three months. 
4.2.5 DETRAINING AND REPEAT PERFORMANCE TESTING 
After the illness and subsequent testing, the athlete was allowed to regain his/her fitness level 




8 km Time trial 
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The weekly distance (km/week) and 8km time trial running time (min) of the 
runners 4 weeks pre - Illness and 4 weeks pre - detraining. Values are mean ±SD. 
Pre - illness Pre - detraining Pvalue 
50.5 ±5.6 49.9 ±5.9 0.92 
33.2 ±0.5 33.0 ±0.49 0.24 
During the final phase the athlete stopped training for the same period he/she detrained during the 
illness. After the simulated detralning period the subject repeated all the testing for muscle strength, 
muscle endurance and aerobic endurance parameters duplicating the tests that were done following 
the period of illness. The tests following the detraining period were compared to the tests following the 
illness period. This was done to determine whether there was a difference in performance when 
comparing detraining associated with illness to detraining alone. As in the case of the tests following 
the illness period the tests following the detraining period are also referred to as Day 0, Day 2, Day 4 
and Day 6. 
4.2.6 STATISTICAL ANALYSIS 
Statistical analysis was done at the Department of Statistics, Medical School of Natal, South Africa, 
using SAS Statistical Software, SAS Institute, USA. Means and standard deviations were used to 
summarise the data. Paired t-tests were used to compare mean of performance parameters between 
tests done on days following illness versus days following detraining. A probability of p < 0,05 was 
considered statistically significant. Performance measurements were not done on one of the subjects 
who developed a bacterial infection of the lower leg. Thus, statistics for all the days were accumulated 
and calculated on five subjects except for the last of each test day following detraining where the 
calculations were made on four subjects. 
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4.3 RESULTS 
4.3.1 INCIDENCE OF URTI IN AN ATHLETIC POPULATION 
A total of 42 volunteers were recruited and performed the baseline tests. During the time the study was 
performed four athletes relocated and nine students from the University of Zululand became 
uncontactable. These subjects were effectively lost to the study, thereby reducing the total to 29 
athletes. Among these 29, there were 22 incidences subjects developing upper respiratory tract illness 
symptoms during the study period. Of these, 3 athletes (10%) reported illness that complied to the 
criteria for URTI, but could not participate further in the study due to political unrest on the University of 
Zululand campus. Another 3 athletes (10%) reported their illness that was clinically confirmed by the 
investigating doctor. Two of these athletes declined to participate further in the study and one 
completed the protocol for post-infection testing but subsequently refused to detrain for the 
comparative study. This athlete had been ill for 14 days and was disinclined to break a rigorously 
maintained training schedule to detrain for an additional 14 days. 
Six patients completed all the test protocols. Of these, one did not maintain his level of fitness after his 
URTI, which rendered his detraining tests invalid. One athlete developed a septic lesion on the leg 
before the final detraining test and this test was not performed. The five subjects who completed both 
test protocols were ill for periods ranging from 5 to 13 days and the mean period of illness was 7 .8 
days. 
4.3.2 PERFORMANCE PARAMETERS POST-ILLNESS 
4.3.2.1 MUSCLE STRENGTH AND ENDURANCE 
Muscle strength parameters following the upper respiratory tract illness and the detraining periods in the 
athletes were tested and is depicted in Table 4.3. 
Table 4.3 
Baseline 









Muscle strength (maximal contraction of Quadriceps muscle for 10 seconds at 
60 degrees/second) following URTI and a detraining period of equal duration. 
Muscle Strength 
Work/ Flexion Flexion Work/ Extension Extension Total 
flexion power torque to extension power torque to work 
(Joule) (Watt) mass (Joule) (Watt) mass (Joule) 
(Nm/kg) (Nm/kg) 
598 ±112 119 ±25 2.32±0.42 439 ±129 95±24 1.65 ±0.39 1037 ±224 
586 ±53 117 ±16 2.10 ±0.40 444±86 96±19 1.58 ±0.36 1029 ±132 
511 ±140 102±30 1.97 ±0.58 410 ±108 88±23 1.47±0.36 921 ±232 
571 ±40 113 ±12 2.20 ±0.43 455 ±129 97±23 1.59 ±0.43 1026 ±155 
559 ±70 109±17 2.09 ±0.48 417 ±116 90±23 1.52 ±0.36 976 ±177 
594 ±83 112 ±15 2.13±0.34 403±96 91 ±24 1.54 ±0.38 997 ±177 
605191 115 ±20 2.19 ±0.41 399 ±103 89±21 1.52 ±0.41 1004 ±190 
558 ±143 106±23 2.02 ±0.49 392:i66 88±18 1.51 ±0.34 950 ±177 
484±84 98 ±12 1.86 ±0.26 396±88 83±23 1.48 ±0.40 880 ±172 
Actual values reported in Mean ±Standard Deviation. Nm/kg = Newton metre/kllogram. 
There were no significant differences in Total work inflexion (Joule), Power in flexion (Watt), Flexion 
torque to mass (Nm/kg), Total work in extension (Joule}, Extension power (Watt), Extension torque to 
mass (Nm/kg), Total work (Joule) and Total power (Watt) between the illness and detraining days on 
days 0, 2, 4 and 6. There were also no significant differences when the post illness and post detraining 
parameters were compared to the baseline tests. 
Muscle endurance parameters were measured following the illness and the detraining periods and is 














Table 4.4 Comparison of muscle endurance (total work done in 35 sec of maximal flexion 
and extension of Quadriceps muscle at 180 degrees) following URTI and a 
detraining period of equal duration. 
Muscle endurance (Joule) 
Baseline tests 
3789 ±717 
Days Illness Detraining p-values 
0 4169 ±765 3996 ±620 0.45 
2 3841 ±814 4130 ±781 0.32 
4 4130 ±873 3939 ±759 0.39 
6 4044 ±962 3949 ±1013 0.15 
Actual values reported in Mean ±Standard Deviation. 
There were no significant differences in muscle endurance work (Joule) when comparing the illness 
period to the detrainlng period on days 0, 2, 4 and 6. Furthermore there were no significant differences 
when comparing baseline data to the post illness and post detraining data. 
These data show that muscle strength and endurance does not seem to be affected by upper 
respiratory tract illness immediately and for at least six days after the resolution of symptoms. The 
muscle strength and endurance also does not seem to be affected by a comparable period of 
detraining. 
4.3.2.2 AEROBIC PHYSIOLOGICAL PARAMETERS 
The parameters measured during the baseline tests at rest and at maximal effort were compared to the 
parameters measured following the illness period and following the detraining period at rest and during 
maximal exercise. Furthermore the tests done following the period of illness were compared to the tests 
done following the detraining period at rest, after 40 minutes endurance at 70% of maximal effort and at 
exhaustion. 
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4.3.2.2.1 RESTING VALUES 
The baseline performance variables recorded at rest and the performance variables recorded following 
the illness period and following the detraining period for each of the four testing days (days 0, 2, 4 and 
6) are depicted and compared in Table 4.5. 
Table 4.5 
Baseline 








Comparison of baseline values to the test values, following illness and 
detraining periods for physiological parameters at rest, and comparison of the 
illness period to the detrainlng period for physiological parameters at rest on 
testing days 0, 2, 4 and 6. 
Physiological parameters at rest 
V02 VC02 RQ METS RF V'e 
(ml/kg/min) (ml/kg/min) (breaths/min) (I/min) 
4.28 ±1 .98 277.8 ±102.4 0.92±0.07 1.22 ±0.55 15.34 ±6.80 10.44 ±3.22 
5.94 ±0.99 394.5±86.7 0.95±0.06 1.70 ±0.31 14.56±7.67 13.44 ±4.50 
6.36 ±4.23 481.0 ±309.3 1.02 ±0.23 1.80 ±1 .20 15.12±3.77 14.54 ±7.96 
4.68 ±1 .34 313.5~7.7 0.92±0.03 1.32 ±0.37 13.72 ±5.70 • 11.28 ±1 .37 
5.97 ±3.02 423.0 ±273.7 1.03±0.12 1.70 ±0.84 17.87 ±8.65 15.50 ±6.83 
6.22 ±3.02 406.6 ±208.0 0.92±0.05 1.78 ±0.85 15.22 ±6.31 13.30 ±5.77 
6.14 ±1.03 • 402.8 ±100.1 • 0.92 ±0.09 1.74 ±0.27 • 15.02 ±6.65 13.14 ±3.37 
6.32 ±2.37 409.2 ±139.3 1.11 ±0.40 1.80 ±0.65 14.34 ±5.29 14.62 ±4.08 
7.60 ±4.09 480.0 ±271 .8 0.87 ±0.04 2.17 ±1.12 13.27 ±4.12 15.37 ±7.68 
Actual values are reported as Mean ±Standard Deviation. f',/02 = oxygen uptake recorded. VC02 = carbon dioxide expired. RQ = 
respiratory quotient METS =metabolic units. RF ::: respiratory frequency in breaths/minute. V'e = volume air inspired andexplred. 
Temp= rectal temperature. • denotes p-value < O.Cl5.) 
There was considerable indMdual variation in actual parameters as is indicated by the large standard 
deviations. In comparison, the resting V02, VC02 and METS were significantly greater (p < 0.05) than 
baseline values on Day 2 following the detraining period. The resting RF was significantly decreased (p 














There were no significant differences between the illness and detraining periods in any of the resting 
measurements. 
4.3.2.2.2 SUBMAXIMAL EXERCISE PARAMETERS 
The performance variables following the period of illness and the performance variables following the 
detraining period taken after 40 minutes endurance running at 70% of maximal effort on testing days 0, 
2, 4 and 6 are depicted and compared in Table 4.6. METS was significantly higher (p < 0.05) in the 
period following illness compared to the same period following detraining on day O and day 2. Likewise, 










Comparison of physiological parameters after a 40 min run at 70% of V02 peak 
post-illness and post-detraining. 
Physiological parameters after 40 minutes exercise at 70% of maximum effort 
V02 VC02 RQ METS RF V'e (Umin) 
(mUkg/min) (mUkg/mi (breaths/m 
n) in) 
43.06±5.52 3128 ±614 0.97±0.03 12.30 ±1 .57 30.92±7.73 73.63 ±14.07 
41.48 ±4.61 3046±583 0.98±0.05 11 .82 ±1 .24 34.78 ±8.99 75.64 ±15.61 
32.58 ±13.78 2203±628 0.75±0.49 9.32 ±3.93 32.08±6.15 69.26 ±10.71 
41.00±3.83 2889 ±615 0.99±0.05 11.53 ±1 .08 36.48±7.25 75.73 ±15.30 
40.74 ±4.23 • 2773±497 0.95 ±0.04 11 .64 ±1.22 • 33.02 ±6.31 72.86 ±12.88 
39.72 ±3.15 • 2689 ±424 0.95±0.04 11 .36 ±0.88 • 34.40 ±6.26 72.36 ±12.59 
36.74 ±6.65 2453±492 0.94 ±0.04 10.50 ±1 .93 30.40±6.96 62.14 ±11.49 
40.93±5.05 2811 ±553 0.95±0.02 11.70 ±1.47 27.97 ±2.80 74.13 ±11.83 
Actual values are reported as Mean ±Standard Deviations. (V02 = oxygen uptake. VC02 = camon dioxide expired. Ra = respiratory 
quotient. METS ::s metabolic units. RF= respiratory frequency in breaths/minute. Ve= volume air Inspired and expired. Temp= 














4.3.2.2.3 MAXIMAL EXERCISE TEST PARAMETERS 
The baseline performance variables at maximal exercise and the performance variables following the 
period of illness and following the detraining period on testing days 0, 2, 4 and 6 are depicted and 
compared in Table 4.7. There were considerable individual variations as depicted by the large standard 
deviations. 
When comparing the baseline tests with the tests following the illness and the detraining periods, there 
were a lower respiratory frequency (RF) and a higher ventilation volume (Y'e) on day O following the 
detraining period. There was no significant difference when baseline tests were compared to tests 
following the period of illness. 
At maximal effort, there were significant differences on comparative days of the post-illness and post 
detraining periods as depicted in Table 4.7. V02 and METS were significantly lower on day O post-
illness, while VC02 and V'e were significantly lower on days 0, 2 and 4 post-illness when compared to 
the corresponding detraining periods. 
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Table 4.7 Comparison of baseline values to the test values following the illness and 
detraining periods for physiological parameters at maximal effort, and 
comparison of the illness period to the detraining period for physiological 
parameters at maximal effort. 
Physiological parameters at maximal effort 
V02 VC02 RQ METS RF V'e Temp 
(mUkg/min) (mUkg/min) (breaths/min) (litres/min) (degrees 
Celsius) 
Baseline 49.7 ±13.0 3839 ±1306 1.07±0.13 14.16 ±3.63 70.22 ±10.44 94.86 ±32.16 38.12 ±0.61 
Illness DayO 53.4±8.06 3920 ±663 1.08 ±0.07 15.26 ±2.32 50.60 ±27.71 103.7 ±18.7 38.92±0.65 
Day2 54.1 ±6.86 4253 ±913 1.12±0.09 15.46 ±1 .94 44.12±7.57 114.4 ±25.1 35.64 ±8.27 
Oay4 56.3±4.02 4594 ±639 1.17 ±0.09 16.08 ±1 .15 47.34 ±8.12 120.4 ±13.4 35.36±7.60 
Oay6 58.3 ±6.43 4566 ±734 1.17 ±0.84 17.37 ±2.96 49.22 ±10.40 132.4 ±19.3 39.02 ±0.80 
Detrain Day 0 58.7±7.45 • 4753 ±835 • 1.13 ±0.06 16.78 ±2.12 • 51 .04 ±7.83 • 130.4 ±23.9 • 35.16±7.72 
Oay2 57.8±6.92 4553 ±694 • 1.11 ±0.01 16.50 ±1 .94 48.02±7.23 125.6 ±21 .8 • 34.14 ±7.76 
Day4 54.9 ±5.23 4345 ±388 1.13 ±0.06 15.50 ±1 .73 48.08±4.88 116.7 ±12.8 33.84±7.82 
Day6 56.6 ±10.26 4689 ±1077 • 1.15 ±0.03 16.13 ±2.94 46.73±3.38 135.9 ±22.4 • 38.83 ±0.86 
Actual values are reported as Mean ±Standard Deviations. (V02 = oxygen uptake. VC02 = maximal carbon dioxide expired. RQ = 
respiratory quotient. METS = metabolic units. RF = respiratory frequency in breaths/minute. V'e "' volume air inspired and expired. 
Temp= rectal temperature. • denotes p-values < 0.00.) 
Figures 4.1, 4.2, 4.3 and 4.4 depict the V02, VC02, V'e and METS at maximal exercise intensity during 
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Figure 4.1 Effect of URTI and detraining on V02 peak in runners 





The mean values of V02 peak following the period of noticeable illness and the period of detraining at 
maximal effort is depicted in Figure 4.1. There is a progressive increase in V02 peak from day O to day 
6 following illness. The difference in V02 peak following illness and following detraining is significant 
only on day 0. 
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Figure 4.2 Effect of URTI and detraining on VC02 expiry in 
runners 
( * : p < 0.05) 
Comparisons of VC02 expiry at maximal effort following the illness and detraining periods are depicted 
in Figure 4.2. There is an incremental increase in the actual mean values of VC02 expiry following 





















Figure 4.3 The effect of URTI and detraining of V'e in runners 
( *: p < 0.05) 
The V'e (volume of air inspired and expired in litres) at maximal effort following the illness and the 
detraining periods are depicted in Figure 4.3. Following illness there is a progressive increase in the 
volume of air expired from day O to day 6 and the differences following the illness and detraining 





















DayO Day2 Day4 Day6 
Testing days 
Figure 4.4 Effect of URTI and detraining on METS in runners 
( * : p < 0.05) 
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The mean values for METS (metabolic units) at maximal performance following the illness and the 
detraining periods are depicted in Figure 4.4. The tests following URTI improve incrementally from day 
0 to day 6 and the values are significantly decreased for the illness test on day O only. 
4.3.2.2.4 TIME TO EXHAUSTION 
A comparison of the time it took the athletes to reach their levels of exhaustion following the illness and 
the detraining periods is indicated in Table 4.8. There were no differences between days 0, 2, 4 and 6 
following the detraining period. However, there was a significant decrease in the time to exhaustion 
following illness on day 0. 
Table4.8 
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Comparison of the time to exhaustion (mean ± SO) following illness period and 
following detraining period during a graded treadmill test to exhaustion after 
running for 40 minutes at 70% of maximal performance on testing days 0, 2, 4 
and 6. 
Time to exhaustion 
Days After illness After detraining p-values 
0 5.20 ±2.49 6.80 ±2.17 0.03• 
2 6.40 ±2.30 7.00 ±1 .14 0.30 
4 6.60 ±1 .95 7.20 ±1.64 0.43 
6 7.27 ±2.63 7.25 ±2.22 1.00 
Actual values reported as means± standard deviation (SO). • indicates p< 0.05. 
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Figure 4.5 Effect of URTI and detraining on treadmill time 
(min) in runners 
( *: p < 0.05) 
There was a progressive increase in the time to exhaustion from day O to day 6 following the URTI 
(Table 4.7 and Figure 4.5). Comparison of the period following illness to the period following detraining 
indicates a significant difference between illness and detraining on day O only. 
4.4 DISCUSSION 
The objectives of this study were to determine the effect of URTI on exercise performance during the 
recovery period from the illness. 
The baseline tests which determined the athletes' physiological parameters both at rest and at 
exhaustion were compared to the tests performed following upper respiratory tract illness and then 
following a comparable period of detraining. This was done to demonstrate possible decreases in 
performance due to the illness and detraining periods. 
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Of the original group of 42 subjects who underwent baseline tests, 29 remained in the study. Twelve 
athletes out of the 29 developed upper respiratory illness over a 4 year period and only five became 
available for testing in the study. This is a small group with large variations as is evident from the 
maximum and mean differences of the values. Differences in the aerobic parameters measured seem 
to follow a trend that can be related to the illness itself and not the concomitant detraining effect. Similar 
differences in muscle strength and muscle endurance tests were not documented. Thus, even with the 
small sample size, the results seem to indicate that URTI has a negative effect on aerobic endurance 
due to the illness. 
When compared to baseline tests at rest, a significant decrease (p < 0.05) in RF was recorded on day 
4 following illness with no significant difference following detraining. The significant difference in RF at 
rest on day 4 following illness is not clear, but might indicate some subclinical impairment of respiratory 
function, or might be due to the small cohort and thus large individual variation as is illustrated by the 
standard deviations. 
Furthermore, when compared to baseline tests, significant increases for V02, VC02 and METS were 
recorded at rest on day 2 following detraining with no significant differences following illness. The 
reason for these increases in V02, VC02 and METS following detraining are not clear but might 
indicate that the period of detraining has a detrimental effect on respiratory function at rest that 
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manifests on day 2 following the initial exercise bout. These increases in V02, VC02 and METS 
following detraining may also indicate an increased metabolic rate following the testing on day 0, which 
had not fully recovered prior to the testing on day 2. The increases in V02, VC02 and METS following 
detraining had disappeared on test day 4 and might indicate that the subject had fully recovered the 
respiratory function and/or metabolic rate as a result of detraining. 
When comparing baseline tests with tests following illness and detraining at maximal performance, 
there is a significant decrease in RF and an increase in V'e on day O following detraining. This might 
once more be evidence of some loss of respiratory function during the detraining period which is 
apparent at maximal performance on day 0, but rapidly recovers once exercise is recommenced and 
has disappeared on day 2. 
The physiological parameters measured at rest, after 40 minutes at 70% of maximal exertion and at 
exhaustion, in both the post-illness and post-detraining periods were compared to determine whether 
possible decreases in performance are due to the illness or due to the detraining period. At rest no 
significant differences were found following the illness or detraining periods. After 40 minutes running at 
70% of maximal exertion, it was found that the V02 and METS were increased significantly on days 0 
and 2 following illness. At maximal effort, all the recorded values were lower following URTI than 
following detraining and decreases were significant in V02 and METS on day 0, and VC02 and V'e on 
days 0, 2 and 6 following the URTI period but not after detraining. 
The reason for the significant increase in the V02 peak and the METS following illness on days O and 2 
after 40 minutes exercise at 70% of maximal exertion is not clear. This might have been due to an 
increase in effort resulting from a subclinical myopathy with resultant increase in oxygen demand and 
increased muscle metabolism. These effects disappeared on days 4 and 6 and this might be due to the 
athlete having recovered by this time after the illness. 
The significant decreases of V02 and METS following illness on days O at maximal exercise and the 
significant decreases ofVC02 and V'e following illness on days 0, 2 and 6 at maximal effort are also not 
clear but might be due to subclinically impaired respiratory function and metabolism as result of the 
upper respiratory tract illness. 
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In summary, comparison of the baseline tests with the tests following illness and the tests following 
detraining seem to indicate that an upper respiratory tract illness lasting from 5 to 13 days might have a 
subclinical effect on the respiratory function and metabolism at rest once the subject has recovered 
from the illness. Furthermore, the period of detraining resulted in a significant loss of aerobic endurance 
ability at maximal effort on day 2 only following this period. Significant differences between the two 
experimental periods of illness and detraining at rest were also found on day 0. This seems to indicate 
that there might be a decrease in athletic performance following detraining due to a loss of endurance 
capacity which recovers after the first two days on commencement of training. 
In comparing the period following detraining to the period following illness at maximal exercise to 
exhaustion, there were decreases in physiological parameters indicating possible subclinical 
pathological sequelae of the illness that may be interfering with respiratory or skeletal muscle function. 
This was demonstrated by decreases in V02 max, VC02, METS and respiratory volume 0J'e) during the 
first day following the illness and decreases in VC02 and V'e for the full six days duration of the testing. 
The testing did not extend beyond the first six days following illness and it is not known when the VC02 
and V'e returned to normal. 
This study is the first to show, that upper respiratory tract illness lasting on average 7,5 days has a 
detrimental effect on exercise performance immediately following the illness. Physiological parameters 
were unaffected at rest. However, there was evidence of increased oxygen consumption and increased 
metabolism during the first two days following illness, when subjects performed submaximal exercise by 
running for 40 minutes at 70% of maximal performance. This would support the findings of a study 
(Daniels et al. 1985) which showed that submaximal exercise performance was near normal following 
febrile illness. 
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Our study also showed that athletes terminated the maximal test earlier following illness than after 
detraining alone. This finding was also reported by Jakeman (1993) who found that an elite cyclist who 
exercised to exhaustion by completing six stages of a graded exercise protocol, was able to complete 
only four stages of this protocol during the first week following a coxsackie viral illness (sp. not 
identified). The reasons for the decreased performance are not clear. but might be the result of 
compromised respiratory functions due to the illness. As demonstrated in this study, the muscle 
strength and muscle endurance do not seem to be affected by the illness, therefore the premature 
termination of exercise to exhaustion might not be due to an abnormality in skeletal muscle functions. 
These findings seem to indicate that there is a significant negative effect of upper respiratory tract 
illness on submaximal exercise performance during the first two days only following the illness, and that 
the negative effect on maximal exercise lasts longer. 
In this study no significant differences between URTI and detraining states were documented in the total 
work performed by isokinetic testing on skeletal muscle (Joule). Likewise for indicators of skeletal 
muscle strength [total power (Watt), work done (Joule) and torque produced {Nm) during flexion and 
extension] there were no significant differences post illness and post detraining. These results seem to 
indicate that an upper respiratory tract illness lasting from 5 to 13 days has no negative effect on either 
skeletal muscle strength nor muscle endurance. This finding is in agreement with previous studies 
which found that changes in muscle parameters due to URTI return to normal almost immediately 
following febrile illness {Friman 1977; Astrom et al. 1979; Friman et al. 1985; Daniels et al. 1985). 
A limitation of this study is the absence of a control group which could have been useful in detecting a 
drift in calibration of apparatus over time. However, the air mixture used during recording of the 
endurance parameters were from one cylinder only and this cylinder was exclusively kept for this study. 
The aerobic apparatus was calibrated prior to each test according to specified parameters and by using 
the same cylinder of air. A further limitation to the study could be a possible learning effect due to 
repeated physiologic testing. The only familiarising with testing procedure was done during the baseline 
testing and that did not include an endurance run for 40 minutes at 70% of maximal endurance. 
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Intensity and duration of training during this study should not be limiting factors as the distances run per 
week were dictated and the time trial times monitored. The intake of anti-oxidants and dietary factors 
could be limitations of this study as they were not controlled nor recorded. 
4.5 SUMMARY 
This study has shown that following an URTI, aerobic endurance capacity but not muscle strength nor 
muscle endurance, is negatively affected. Upper respiratory tract illness has a significant effect on 
performance parameters during submaximal endurance exercise in the first two days only following an 
URTI. However, during maximal exercise, upper respiratory tract illness has a significant detrimental 
effect on endurance parameters during the first six days immediately following the illness and possibly 
for longer. 
The illness appears to be responsible for some loss of respiratory function which recovers by the fqurth 
day following the active period of illness. Oetraining alone significantly decreases endurance capacity, 
but this recovers rapidly within 2 days of recommencing endurance training. 
In future studies, it may be necessary to extend the testing period beyond six days following upper 
respiratory tract illness to determine how long it takes for respiratory parameters to recover such that 
exercise to exhaustion is not impaired. Such a study could also attempt to determine whether the 
premature termination of effort to exhaustion following illness is due to respiratory factors, skeletal 
muscle factors or central factors. Another question that remains unanswered is whether the apparent 
protective effect that regular endurance exercise has on the risk of developing an upper respiratory tract 
illness is due to the exercise per se or due to the athletes being a selected group who conscientiously 
practice methods to avoid contracting illness. 
In summary this thesis shows that there is a low risk of URTI in moderately trained endurance athletes. 
However, in athletes an URTI can also decrease submaximal endurance performance for the first two 
days following the illness, and decrease maximal performance for longer than six days following the 
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illness. This decrease in performance is not only due to detraining. As muscle strength and endurance 
does not appear to be negatively affected by URTI, athletes participating in events that depend on 
strength and power as opposed to aerobic endurance would probably not be handicapped. 
Appendix 1 
APPENDICES 
UNIVERSITY OF ZULULAND 
DEPARTMENT OF HUMAN MOVEMENT SCIENCE 
SUBJECT CONSENT FORM 
l, ______________________ of (address) 
having been fully informed of the nature of the research entitled: 
THE EFFECT OF UPPER RESPIRATORY TRACT ILLNESS ON EXERCISE PERFORMANCE 
do hereby give my consent to act as a subject in the above-named research. 
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I am fully aware of the procedures involved as well as the potential risks and benefits attendant to my participation as explained to me. In agreeing to participate in this research, I waive any legal recourse against the researchers of the University of Zululand, any and all claims resulting from personal injuries sustained. This waiver shall be binding upon my heirs and personal representatives. I realise that it is necessary for me to promptly report to the researcher any signs or symptoms indicating any abnormality or distress. 
I am aware that I may withdraw my consent and withdraw from participation in the research at any time. I am aware that my anonymity will be protected at all times and agree that the information collected may be used and published for statistical or scientific purposes. 
I have read the foregoing and understand it. Any questions which may have occurred to me have been answered to my satisfaction. 
Subject: 
(Print name) 











Personal and Medical History 
Name: 
Sex: I Race: I Date of birth: 
Occupation: 
In which sports do you participate? 
Haye you ever been prohibited from participating in sport for medical reasons? 
If Yes, describe: 
Have you had an operation or ever been advised to have an operation? 
If Yes, describe: 
Do you have or have you ever suffered from the following: 
Indicate with an X No Yes Indicate with an X 
Ear Nose Throat Sinusitis 
Frequent colds Frequent headaches 
Hay fever Migraine 
Asthma Allergies 
Rheumatic fever Painful joints 
Tuberculosis Epilepsy 
Serious accident Head injury 
Thyroid problems Persistent coughing 
High blood pressure Palpitations 
Low blood pressure Diabetes 






Medical Examination Date: 
Name: I Age: 
General medlcal examination - - Describe abnormality 
Head, face, neck 
Nose 
Sinuses 
Mouth and throat 
Ears 











Body Build: Slender Average Muscular I Fat 
Blood pressure: Supine: Sitting: 
Resting pulse rate: 
Urine: Protein Blood Leukocytes I Glucose 
ECG comment: 
Summary of disabilities and diagnosjs: 
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Appendix 4 
Weekly training schedule Starting date: 
Kilometres run per week 








8km time trial times weekly 
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Appendix 5. 
Medical examination on commencement of Upper Respiratory Tract Illness I Name: I Date: 




















Listing of Symptoms and Signs during Upper Respiratory Tract Illness 
Date when last trained: Date when illness started: 
Scale for grading of symptoms and signs Howdo 
you perceive your symptoms? If the symptom is absent you mark O for none. If there is slight cfiscomfort you 
mark+ for light. If there is definite discomfort you mark ++ for moderate. I there is extreme discomfort you 















To be taken each morning on waking up I Pu~erate 
Temperature 111 11111 11111111111 





Date of birth: I Height: I Mass: 
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